- en: <!--yml
  id: totrans-0
  prefs: []
  type: TYPE_NORMAL
  zh: <!--yml
- en: 'category: 未分类'
  id: totrans-1
  prefs: []
  type: TYPE_NORMAL
  zh: 类别：未分类
- en: 'date: 2024-09-08 18:47:48'
  id: totrans-2
  prefs: []
  type: TYPE_NORMAL
  zh: 日期：2024-09-08 18:47:48
- en: -->
  id: totrans-3
  prefs: []
  type: TYPE_NORMAL
  zh: -->
- en: 'CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments'
  id: totrans-4
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: CRISPR-GPT：一个用于基因编辑实验自动设计的大语言模型代理
- en: 来源：[https://ar5iv.labs.arxiv.org/html/2404.18021](https://ar5iv.labs.arxiv.org/html/2404.18021)
  id: totrans-5
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: 来源：[https://ar5iv.labs.arxiv.org/html/2404.18021](https://ar5iv.labs.arxiv.org/html/2404.18021)
- en: Kaixuan Huang^(1,†), Yuanhao Qu^(2,3,†), Henry Cousins^(4,5), William A. Johnson²,
  id: totrans-6
  prefs: []
  type: TYPE_NORMAL
  zh: 黄凯旋^(1,†)、屈元浩^(2,3,†)、亨利·库辛斯^(4,5)、威廉·A·约翰逊²，
- en: Di Yin², Mihir Shah⁴, Denny Zhou⁶, Russ Altman^(4,7), Mengdi Wang^(1,8,∗), Le
    Cong^(2,∗)
  id: totrans-7
  prefs: []
  type: TYPE_NORMAL
  zh: 殷迪²、米希尔·沙阿⁴、丹尼·周⁶、拉斯·奥特曼^(4,7)、孟迪·王^(1,8,∗)、李聪^(2,∗)
- en: ¹Department of Electrical and Computer Engineering, Princeton University
  id: totrans-8
  prefs: []
  type: TYPE_NORMAL
  zh: ¹普林斯顿大学电气与计算机工程系
- en: ²Department of Pathology, Department of Genetics, Stanford University School
    of Medicine
  id: totrans-9
  prefs: []
  type: TYPE_NORMAL
  zh: ²斯坦福大学医学院病理学系、遗传学系
- en: ³Cancer Biology Program, Stanford University School of Medicine,
  id: totrans-10
  prefs: []
  type: TYPE_NORMAL
  zh: ³斯坦福大学医学院癌症生物学项目，
- en: ⁴Department of Medicine, Stanford University School of Medicine
  id: totrans-11
  prefs: []
  type: TYPE_NORMAL
  zh: ⁴斯坦福大学医学院内科学系
- en: ⁵Medical Scientist Training Program, Stanford University School of Medicine,
  id: totrans-12
  prefs: []
  type: TYPE_NORMAL
  zh: ⁵斯坦福大学医学院医学科学训练项目，
- en: ⁶Google DeepMind
  id: totrans-13
  prefs: []
  type: TYPE_NORMAL
  zh: ⁶谷歌 DeepMind
- en: ⁷Department of Bioengineering, Department of Genetics, Stanford University,
  id: totrans-14
  prefs: []
  type: TYPE_NORMAL
  zh: ⁷斯坦福大学生物工程系、遗传学系，
- en: ⁸Center for Statistics and Machine Learning, Princeton University (April 2024)
  id: totrans-15
  prefs: []
  type: TYPE_NORMAL
  zh: ⁸普林斯顿大学统计与机器学习中心（2024年4月）
- en: Abstract
  id: totrans-16
  prefs:
  - PREF_H6
  type: TYPE_NORMAL
  zh: 摘要
- en: The introduction of genome engineering technology has transformed biomedical
    research, making it possible to make precise changes to genetic information. However,
    creating an efficient gene-editing system requires a deep understanding of CRISPR
    technology, and the complex experimental systems under investigation. While Large
    Language Models (LLMs) have shown promise in various tasks, they often lack specific
    knowledge and struggle to accurately solve biological design problems. In this
    work, we introduce CRISPR-GPT, an LLM agent augmented with domain knowledge and
    external tools to automate and enhance the design process of CRISPR-based gene-editing
    experiments. CRISPR-GPT leverages the reasoning ability of LLMs to facilitate
    the process of selecting CRISPR systems, designing guide RNAs, recommending cellular
    delivery methods, drafting protocols, and designing validation experiments to
    confirm editing outcomes. We showcase the potential of CRISPR-GPT for assisting
    non-expert researchers with gene-editing experiments from scratch and validate
    the agent’s effectiveness in a real-world use case. Furthermore, we explore the
    ethical and regulatory considerations associated with automated gene-editing design,
    highlighting the need for responsible and transparent use of these tools. Our
    work aims to bridge the gap between beginner biological researchers and CRISPR
    genome engineering techniques, and demonstrate the potential of LLM agents in
    facilitating complex biological discovery tasks.
  id: totrans-17
  prefs: []
  type: TYPE_NORMAL
  zh: 基因组工程技术的引入已经彻底改变了生物医学研究，使得精确修改遗传信息成为可能。然而，创建一个高效的基因编辑系统需要对CRISPR技术以及复杂的实验系统有深刻的理解。虽然大语言模型（LLMs）在各种任务中表现出了潜力，但它们通常缺乏特定知识，并且难以准确解决生物设计问题。在这项工作中，我们介绍了CRISPR-GPT，一种增强了领域知识和外部工具的大语言模型代理，用于自动化和增强基于CRISPR的基因编辑实验的设计过程。CRISPR-GPT利用大语言模型的推理能力，促进选择CRISPR系统、设计引导RNA、推荐细胞递送方法、起草协议以及设计验证实验以确认编辑结果的过程。我们展示了CRISPR-GPT在帮助非专业研究人员从头开始进行基因编辑实验方面的潜力，并验证了该代理在实际使用中的有效性。此外，我们探讨了与自动化基因编辑设计相关的伦理和监管问题，强调了这些工具的负责任和透明使用的必要性。我们的工作旨在弥合初学者生物研究人员与CRISPR基因组工程技术之间的差距，并展示大语言模型代理在促进复杂生物发现任务中的潜力。
- en: '^($\dagger$)^($\dagger$)footnotetext: These authors contributed equally to
    this work.^*^*footnotetext: Correspondence to: mengdiw@princeton.edu (M.W.), congle@stanford.edu
    (L.C.)'
  id: totrans-18
  prefs: []
  type: TYPE_NORMAL
  zh: ^($\dagger$)^($\dagger$)脚注：这些作者对本工作贡献相同。^*^*脚注：通讯作者：mengdiw@princeton.edu（M.W.）、congle@stanford.edu（L.C.）
- en: 1 Introduction
  id: totrans-19
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 1 引言
- en: Gene editing technology represents a groundbreaking scientific advancement that
    enables precise alterations to the genetic material of living organisms. This
    innovative technique has found extensive applications across various fields of
    biology and medicine, from correcting genetic defects responsible for disorders
    like cystic fibrosis, hemophilia, and sickle cell anemia, to offering new strategies
    in the battle against complex conditions such as cancer, cardiovascular diseases,
    neurodegenerative disorders, and infections. A most well-known gene editing system
    is called CRISPR-Cas9 [[17](#bib.bib17), [34](#bib.bib34), [25](#bib.bib25), [42](#bib.bib42),
    [6](#bib.bib6), [39](#bib.bib39), [45](#bib.bib45)]. It was adapted from a naturally
    occurring genome editing system that bacteria use as an immune defense. Beyond
    CRISPR-Cas9, recent advancements have led to the development of CRISPR activation/interference,
    CRISPR-based prime editing and base editing technologies. CRISPR activation/interference,
    also called CRISPRa/CRISPRi, are able to either enhance gene expression or silence
    the activities of specific genes via epigenetic regulation [[40](#bib.bib40),
    [20](#bib.bib20), [29](#bib.bib29), [33](#bib.bib33), [38](#bib.bib38)]. Prime
    editing, considered a ”search and replace” method for DNA, allows for precise
    editing capabilities without introducing double-stranded breaks [[7](#bib.bib7)].
    Base editing, on the other hand, enables the direct, irreversible conversion of
    one DNA base into another at targeted locations, further expanding the toolkit
    for precise genome modification [[19](#bib.bib19)]. All these technologies hold
    potential for broad applications in medicine, agriculture, and beyond, enhancing
    the scope of genome editing in pursuing treatments for genetic diseases and other
    applications.
  id: totrans-20
  prefs: []
  type: TYPE_NORMAL
  zh: 基因编辑技术代表了一项突破性的科学进展，它可以对活生物体的遗传物质进行精确的修改。这一创新技术在生物学和医学的多个领域中得到了广泛应用，从修正引起囊性纤维化、血友病和镰状细胞贫血等疾病的遗传缺陷，到为应对癌症、心血管疾病、神经退行性疾病和感染等复杂病症提供新的策略。一个最知名的基因编辑系统叫做**CRISPR-Cas9** [[17](#bib.bib17),
    [34](#bib.bib34), [25](#bib.bib25), [42](#bib.bib42), [6](#bib.bib6), [39](#bib.bib39),
    [45](#bib.bib45)]。它源自于细菌作为免疫防御系统使用的自然发生的基因组编辑系统。除了**CRISPR-Cas9**之外，最近的进展还导致了**CRISPR激活/干扰**、**CRISPR基础编辑**和**CRISPR目标编辑**技术的发展。**CRISPR激活/干扰**，也叫做**CRISPRa/CRISPRi**，能够通过表观遗传调控增强基因表达或沉默特定基因的活动 [[40](#bib.bib40),
    [20](#bib.bib20), [29](#bib.bib29), [33](#bib.bib33), [38](#bib.bib38)]。**基础编辑**，被认为是一种DNA的“搜索和替换”方法，允许精确的编辑能力而不引入双链断裂 [[7](#bib.bib7)]。另一方面，**目标编辑**允许在特定位置直接、不可逆地将一种DNA碱基转换为另一种碱基，进一步扩展了精确基因组修改的工具箱 [[19](#bib.bib19)]。所有这些技术在医学、农业及其他领域都具有广泛的应用潜力，提升了基因组编辑在寻求遗传疾病治疗和其他应用中的范围。
- en: '![Refer to caption](img/e147e42b5527011109fb712ed17e3141.png)'
  id: totrans-21
  prefs: []
  type: TYPE_IMG
  zh: '![参考说明](img/e147e42b5527011109fb712ed17e3141.png)'
- en: 'Figure 1: Overview of CRISPR-GPT Agent. The CRISPR-GPT is built upon an LLM-powered
    design and planning engine (left), which helps to complete 4 core meta-tasks (top
    right), as well as other auxiliary functions (freestyle Q&A, off-target prediction).
    CRISPR-GPT has integrated a set of useful skills and toolkits (bottom right) that
    the LLM agent would call when needed to facilitate human users across the different
    tasks and subtasks. Figure created with BioRender.com.'
  id: totrans-22
  prefs: []
  type: TYPE_NORMAL
  zh: 图1：CRISPR-GPT代理概述。**CRISPR-GPT**建立在一个基于LLM（大型语言模型）设计和规划引擎之上（左），它帮助完成4个核心的元任务（右上），以及其他辅助功能（自由问答、脱靶预测）。**CRISPR-GPT**集成了一套有用的技能和工具包（右下），当需要时，LLM代理会调用这些技能和工具包来帮助用户完成不同的任务和子任务。图由
    BioRender.com 创建。
- en: Designing gene-editing experiments requires deep understanding of the suite
    of technologies and the associated biology of target organs. CRISPR Cas-based
    editing works by interacting with the RNA of a short ”guide” sequence (guide RNA)
    that binds to a specific target sequence in a cell’s DNA, much like the RNA segments
    bacteria produce from the CRISPR array. When introduced into cells, the guide
    RNA recognizes the intended DNA sequence, and the Cas enzyme (often Cas9 or others)
    cuts the DNA at the targeted location, mirroring the process in bacteria. There
    are numerous considerations when designing such experiments, including the selection
    of a well-suited gene-editing system, the development of optimal guide sequences,
    and validation approach. This typically requires significant domain expertise,
    understanding of biology of the target organ, as well as trial-and-error efforts.
    Developing AI-assisted computation tools to aid gene-editing holds great promise
    to make the technology more accessible and accelerate both scientific and therapeutic
    developments.
  id: totrans-23
  prefs: []
  type: TYPE_NORMAL
  zh: 设计基因编辑实验需要深入了解相关技术和目标器官的生物学。基于CRISPR Cas的编辑通过与短“引导”序列（引导RNA）的RNA相互作用来进行，这些引导RNA会结合到细胞DNA中的特定目标序列，就像细菌从CRISPR阵列中产生的RNA片段一样。当引导RNA引入细胞时，它会识别预期的DNA序列，Cas酶（通常是Cas9或其他酶）会在目标位置切割DNA，这一过程与细菌中的过程相似。在设计此类实验时，有许多考虑因素，包括选择合适的基因编辑系统、开发最佳引导序列以及验证方法。这通常需要丰富的领域专业知识、对目标器官生物学的理解以及反复试验的努力。开发AI辅助计算工具以协助基因编辑具有极大的潜力，可以使该技术更加易于获取，加速科学和治疗的发展。
- en: Large language models (LLMs) have demonstrated exceptional capabilities in language
    skills and encapsulate a tremendous amount of world knowledge, approximating aspects
    of artificial general intelligence [[13](#bib.bib13), [24](#bib.bib24), [3](#bib.bib3),
    [5](#bib.bib5), [4](#bib.bib4)]. Recent research has also explored enhancing LLMs
    with external tools, improving their problem-solving abilities and efficiency [[53](#bib.bib53),
    [32](#bib.bib32), [44](#bib.bib44)]. LLMs have also demonstrated potential as
    tool makers [[10](#bib.bib10)] and black-box optimizers [[52](#bib.bib52)]. Researchers
    have explored LLM-based specialized models for various application domains [[31](#bib.bib31),
    [51](#bib.bib51)], as well as for solving scientific and mathematical tasks. For
    example, ChemCrow [[9](#bib.bib9)] uses tool-augmented LM for solving a range
    of chemistry-related tasks such as paracetamol synthesis, whereas Coscientist [[8](#bib.bib8)],
    also driven by GPT-4 and integrated automated experimentation, achieved successful
    optimization of palladium-catalyzed cross-coupling reaction.
  id: totrans-24
  prefs: []
  type: TYPE_NORMAL
  zh: 大型语言模型（LLMs）在语言技能方面展示了卓越的能力，并 encapsulate 了大量的世界知识，接近人工通用智能的某些方面[[13](#bib.bib13)、[24](#bib.bib24)、[3](#bib.bib3)、[5](#bib.bib5)、[4](#bib.bib4)]。近期研究还探索了通过外部工具增强LLMs，以提高其解决问题的能力和效率[[53](#bib.bib53)、[32](#bib.bib32)、[44](#bib.bib44)]。LLMs也展现了作为工具制造者[[10](#bib.bib10)]和黑箱优化器[[52](#bib.bib52)]的潜力。研究人员探索了基于LLM的专门模型用于各种应用领域[[31](#bib.bib31)、[51](#bib.bib51)]，以及解决科学和数学任务。例如，ChemCrow[[9](#bib.bib9)]使用工具增强的LM解决了一系列与化学相关的任务，如对乙酰氨基酚合成，而Coscientist[[8](#bib.bib8)]，也由GPT-4驱动并集成了自动化实验，成功优化了钯催化的交叉偶联反应。
- en: 1.1 General-purpose LLMs do not know how to design biological experiments.
  id: totrans-25
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 1.1 通用LLMs不知道如何设计生物实验。
- en: While leveraging large language models (LLMs) for aiding in the design of gene-editing
    experiments presents an enticing prospect, the current state-of-the-art general-purpose
    models exhibit significant shortcomings in this specialized domain. These models,
    despite their vast knowledge base, lack the precise, up-to-date domain-specific
    knowledge essential for the accurate design of biological experiments.
  id: totrans-26
  prefs: []
  type: TYPE_NORMAL
  zh: 尽管利用大型语言模型（LLMs）来协助设计基因编辑实验展现了诱人的前景，但目前最先进的通用模型在这一专门领域存在显著不足。尽管这些模型拥有广泛的知识基础，但缺乏准确设计生物实验所需的精确、最新的领域特定知识。
- en: A critical limitation of general-purpose LLMs is their propensity for ”hallucinations”
    or generating confident yet inaccurate responses when tasked with specialized
    biological queries. For instance, when tasked with designing a guide RNA (gRNA)
    sequence for targeting specific human genes, such as EMX1 or EGFR, general-purpose
    LLMs like ChatGPT-3/ChatGPT-4 can respond incorrect sequence with high confidence.
    However, the gRNA sequences they provide often do not correspond to any known
    genomic region. This discrepancy can be readily identified by comparing the LLM-generated
    sequences with reference sequences in databases such as the NCBI’s BLAST tool,
    which aligns sequences to the human genome and transcriptome. Such hallucinated
    design sequences not only lack utility but can mislead researchers, potentially
    leading to wasted resources and time if not properly vetted.
  id: totrans-27
  prefs: []
  type: TYPE_NORMAL
  zh: 通用LLMs的一个关键局限是它们倾向于产生“幻觉”，即在处理专门的生物学查询时生成自信但不准确的回答。例如，当被要求设计一个针对特定人类基因（如EMX1或EGFR）的引导RNA（gRNA）序列时，像ChatGPT-3/ChatGPT-4这样的通用LLMs可能会以高度自信的态度提供不正确的序列。然而，它们提供的gRNA序列通常与已知的基因组区域不符。这种不一致可以通过将LLM生成的序列与数据库中的参考序列（例如NCBI的BLAST工具，它将序列与人类基因组和转录组对齐）进行比较来轻松识别。这些幻觉设计序列不仅没有实用性，还可能误导研究人员，如果没有经过适当审查，可能导致资源和时间的浪费。
- en: In addition, responses generated from general-purpose LLMs usually lack essential
    details necessary for the experimental design, such as specific materials, protocols,
    considerations for off-target effects, gRNA efficiency, and specificity. Such
    gaps in information can leave researchers, especially those new to the field of
    gene editing, unprepared for the practical execution of experiments.
  id: totrans-28
  prefs: []
  type: TYPE_NORMAL
  zh: 此外，一般用途的LLMs生成的响应通常缺乏实验设计所需的关键细节，如具体材料、操作规程、对非靶向效应的考虑、gRNA效率和特异性。这些信息的缺失可能使研究人员，特别是那些刚刚接触基因编辑领域的人，无法为实验的实际执行做好准备。
- en: Furthermore, it is crucial to note that responses generated may contain overwhelming
    information that does not directly contribute to the gene-editing experimental
    designs. Such irrelevant text can lead to confusion and misdirection, complicating
    the researcher’s task of identifying the most pertinent and practical information
    for their gene-editing objectives.
  id: totrans-29
  prefs: []
  type: TYPE_NORMAL
  zh: 此外，需要特别注意的是，生成的响应可能包含大量不直接贡献于基因编辑实验设计的信息。这些无关的文本可能导致混淆和误导，使研究人员在识别最相关和实用的信息以实现其基因编辑目标时面临困难。
- en: 'All of these limitations underscore the necessity for a new class of LLMs tailored
    specifically for the gene-editing experimental designs (We refer readers to Appendix [A](#A1
    "Appendix A Failure Cases of GPT-4 ‣ CRISPR-GPT: An LLM Agent for Automated Design
    of Gene-Editing Experiments") for more examples of failures). Such models would
    need to integrate deep, accurate domain knowledge with the ability to critically
    evaluate and generate experimentally viable solutions, thereby overcoming the
    current barriers faced by general-purpose LLMs in the design of CRISPR gene-editing
    experiments.'
  id: totrans-30
  prefs: []
  type: TYPE_NORMAL
  zh: 所有这些局限性突显了需要一种新的LLMs类型，这种类型的LLMs专门针对基因编辑实验设计（有关失败的更多示例，请参阅附录 [A](#A1 "附录 A GPT-4
    失败案例 ‣ CRISPR-GPT：用于基因编辑实验自动化设计的LLM代理")）。这类模型需要将深厚、准确的领域知识与批判性评估和生成实验上可行的解决方案的能力结合起来，从而克服目前通用LLMs在CRISPR基因编辑实验设计中面临的障碍。
- en: 1.2 Overview of CRISPR-GPT
  id: totrans-31
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 1.2 CRISPR-GPT概述
- en: In the rapidly evolving field of genetic engineering, CRISPR technology has
    become a pivotal tool for precise gene editing. Despite its promise, the intricacy
    of designing CRISPR experiments—from guide RNA (gRNA) selection to predicting
    off-target effects—presents significant challenges, especially to those new to
    the field. To bridge this gap, we introduce CRISPR-GPT, a novel solution that
    combines the strengths of Large Language Models (LLMs) with domain-specific knowledge
    and computational tools, specifically tailored for CRISPR gene editing tasks.
  id: totrans-32
  prefs: []
  type: TYPE_NORMAL
  zh: 在快速发展的基因工程领域，CRISPR技术已经成为精确基因编辑的重要工具。尽管它承诺了许多好处，但设计CRISPR实验的复杂性——从引导RNA（gRNA）选择到预测非靶向效应——给特别是新入门的人带来了重大挑战。为了解决这一问题，我们引入了CRISPR-GPT，一种结合了大型语言模型（LLMs）的优势、领域特定知识和计算工具的新解决方案，专门针对CRISPR基因编辑任务进行量身定制。
- en: 'CRISPR-GPT is centered around a tailor-made LLM-powered design and planning
    agent (Figure [1](#S1.F1 "Figure 1 ‣ 1 Introduction ‣ CRISPR-GPT: An LLM Agent
    for Automated Design of Gene-Editing Experiments")). This engine of the agent
    not only draws upon expert knowledge from leading practitioners in gene editing
    but also integrates a broad review of recent literature and a suite of computational
    toolkits including guideRNA design tool.'
  id: totrans-33
  prefs: []
  type: TYPE_NORMAL
  zh: 'CRISPR-GPT围绕一个量身定制的LLM驱动设计和规划代理（图[1](#S1.F1 "Figure 1 ‣ 1 Introduction ‣ CRISPR-GPT:
    An LLM Agent for Automated Design of Gene-Editing Experiments)")展开。该代理的引擎不仅借鉴了基因编辑领域领先实践者的专家知识，还整合了广泛的最新文献回顾和一套计算工具包，包括guideRNA设计工具。'
- en: 'The innovation of CRISPR-GPT Agent allows automated designs of gene-editing
    experiments by simplifies the complex process into a series of manageable steps:'
  id: totrans-34
  prefs: []
  type: TYPE_NORMAL
  zh: CRISPR-GPT代理的创新允许通过将复杂过程简化为一系列可管理的步骤来自动设计基因编辑实验：
- en: •
  id: totrans-35
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: 'Selection of CRISPR System: Tailoring the choice of CRISPR system to the experiment’s
    needs.'
  id: totrans-36
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: CRISPR系统选择：根据实验的需求量身定制CRISPR系统的选择。
- en: •
  id: totrans-37
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: 'gRNA Design: Optimizing guide RNA sequences for efficiency and specificity
    based on the Broad Institute’s gold-standard guideRNA library and CRISPRPick toolkit,
    including pre-designed gRNA libraries [[28](#bib.bib28), [14](#bib.bib14), [15](#bib.bib15),
    [43](#bib.bib43)].'
  id: totrans-38
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: gRNA设计：根据Broad Institute的金标准guideRNA库和CRISPRPick工具包优化引导RNA序列的效率和特异性，包括预设计的gRNA库[[28](#bib.bib28),
    [14](#bib.bib14), [15](#bib.bib15), [43](#bib.bib43)]。
- en: •
  id: totrans-39
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: 'Delivery Approach Selection: Advising on the most effective methods to introduce
    the CRISPR components into target cells.'
  id: totrans-40
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 交付方法选择：建议将CRISPR组件引入目标细胞的最有效方法。
- en: •
  id: totrans-41
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: 'Prediction of Off-target Effects: Assessing potential unintended alterations
    alongside desired edits.'
  id: totrans-42
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 对靶外效应的预测：评估潜在的非预期变化以及期望的编辑。
- en: •
  id: totrans-43
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: 'Recommendation of Experimental Protocols: Outlining step-by-step procedures
    tailored to the experiment’s objectives.'
  id: totrans-44
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 实验协议推荐：概述针对实验目标的逐步程序。
- en: •
  id: totrans-45
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: 'Validation Approach Recommendation and Primer Design: Recommending gest ways
    to validate the edits and help design the associated primers.'
  id: totrans-46
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 验证方法推荐和引物设计：推荐验证编辑的最佳方法，并帮助设计相关引物。
- en: 'This approach, leveraging a chain-of-thought reasoning model and state machines,
    ensures that even individuals new to gene editing can iteratively refine their
    experimental designs to achieve protocols that meet their specific research needs.
    In addition, CRISPR-GPT offers:'
  id: totrans-47
  prefs: []
  type: TYPE_NORMAL
  zh: 这种方法利用链式思维推理模型和状态机，确保即使是基因编辑新手也能迭代地完善实验设计，以实现符合其具体研究需求的方案。此外，CRISPR-GPT还提供：
- en: •
  id: totrans-48
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: A Freestyle Q&A Mode for addressing ad hoc queries with precision,
  id: totrans-49
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 自由问答模式：精确解答临时查询。
- en: •
  id: totrans-50
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: An Off-target Prediction Mode for in-depth analysis of pre-designed gRNAs.
  id: totrans-51
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 针对预设计gRNAs的靶外预测模式进行深入分析。
- en: These functions help the users when they meet additional issues during the experimental
    design process.
  id: totrans-52
  prefs: []
  type: TYPE_NORMAL
  zh: 这些功能帮助用户在实验设计过程中遇到额外问题时。
- en: Mindful of the ethical and safety considerations surrounding gene editing, especially
    in human applications, we have integrated safeguards into CRISPR-GPT. These include
    restrictions on its use in human subjects, measures to ensure the privacy of genetic
    information, and alerts for potential unintended consequences, reflecting our
    commitment to responsible use in alignment with the broader scientific and ethical
    discourse on gene editing technologies.
  id: totrans-53
  prefs: []
  type: TYPE_NORMAL
  zh: 鉴于基因编辑，尤其是在人体应用中的伦理和安全考虑，我们已在CRISPR-GPT中集成了保护措施。这些措施包括对人体受试者使用的限制，确保遗传信息隐私的措施，以及对潜在非预期后果的警告，体现了我们在基因编辑技术的广泛科学和伦理讨论中负责任使用的承诺。
- en: 2 Methods and Algorithms
  id: totrans-54
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 2 方法和算法
- en: 2.1 Large Language Model
  id: totrans-55
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 2.1 大型语言模型
- en: 'The CRISPR-GPT agent consists of the following 4 core modules (Figure [2](#S2.F2
    "Figure 2 ‣ 2.1 Large Language Model ‣ 2 Methods and Algorithms ‣ CRISPR-GPT:
    An LLM Agent for Automated Design of Gene-Editing Experiments")): LLM planner,
    Tool provider, Task executor, and the LLM Agent that serve as the interface with
    users for taking inputs and communicate outputs.'
  id: totrans-56
  prefs: []
  type: TYPE_NORMAL
  zh: 'CRISPR-GPT代理包括以下4个核心模块（图[2](#S2.F2 "Figure 2 ‣ 2.1 Large Language Model ‣ 2
    Methods and Algorithms ‣ CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing
    Experiments)"): LLM规划器、工具提供者、任务执行者和LLM代理，这些模块作为用户界面，用于接收输入和传达输出。'
- en: '![Refer to caption](img/f33795433d978095cc6fdd9192f15c95.png)'
  id: totrans-57
  prefs: []
  type: TYPE_IMG
  zh: '![参见说明](img/f33795433d978095cc6fdd9192f15c95.png)'
- en: 'Figure 2: Components of CRISPR-GPT enable human-AI collaboration to automate
    gene-editing experimental designs across complex tasks. LLM Planner is responsible
    for configuring tasks based on the user’s needs (4 predefined meta-tasks or LLM
    planned chain of tasks). Tool Provider connects the system to external APIs, tools,
    libraries, and documents. Task Executor is implemented as a state machine, responsible
    for providing instructions and feedback, receiving input from LLM Agent, and calling
    APIs via Tool Provider. LLM Agent is responsible for interacting with the task
    executor on behalf of the user, where the user can monitor the process and provide
    correction to the LLM agent if the generated content.'
  id: totrans-58
  prefs: []
  type: TYPE_NORMAL
  zh: 图2：CRISPR-GPT 的组件使人类与人工智能合作，以自动化基因编辑实验设计，涵盖复杂任务。LLM 规划器负责根据用户的需求（4个预定义的元任务或LLM规划的任务链）配置任务。工具提供者将系统连接到外部
    API、工具、库和文档。任务执行器以状态机的形式实现，负责提供指令和反馈，从LLM代理接收输入，并通过工具提供者调用 API。LLM代理负责代表用户与任务执行器交互，用户可以监控过程并在生成内容有误时对LLM代理进行纠正。
- en: Task Executor operates as state machines, providing robust subgoal decomposition
    and progress control.
  id: totrans-59
  prefs:
  - PREF_H4
  type: TYPE_NORMAL
  zh: 任务执行器作为状态机运作，提供强大的子目标分解和进度控制。
- en: 'We implement 22 tasks, summarized in Table [1](#S3.T1 "Table 1 ‣ 3.1.1 Meta
    Mode ‣ 3.1 CRISPR-GPT assists researchers with gene-editing experimental design
    through three modules. ‣ 3 Results ‣ CRISPR-GPT: An LLM Agent for Automated Design
    of Gene-Editing Experiments"), in the form of state machines for CRISPR-GPT. The
    state machines are responsible for providing sufficient instruction for the current
    task and guiding the user to fulfill the decision-making through multiple rounds
    of textual interactions. Through these state machines, we manually decompose each
    task into sub-goals for the task executor. Specifically, each state is responsible
    for one particular sub-goal. The transition logic is well-defined so the task
    executor can properly transit to another sub-goal based on the current progress.'
  id: totrans-60
  prefs: []
  type: TYPE_NORMAL
  zh: '我们实施了22个任务，概述见表格 [1](#S3.T1 "表1 ‣ 3.1.1 元模式 ‣ 3.1 CRISPR-GPT通过三个模块帮助研究人员进行基因编辑实验设计
    ‣ 3 结果 ‣ CRISPR-GPT: 一个用于自动化基因编辑实验设计的大型语言模型代理")，以状态机的形式用于CRISPR-GPT。这些状态机负责为当前任务提供充分的指令，并通过多轮文本互动指导用户完成决策。通过这些状态机，我们手动将每个任务分解为子目标，供任务执行器使用。具体而言，每个状态负责一个特定的子目标。转换逻辑定义明确，因此任务执行器可以根据当前进展适当地过渡到另一个子目标。'
- en: 'We have 4 predefined Meta-Tasks that support the full pipelines of 4 gene-editing-related
    experiments; see Table [1](#S3.T1 "Table 1 ‣ 3.1.1 Meta Mode ‣ 3.1 CRISPR-GPT
    assists researchers with gene-editing experimental design through three modules.
    ‣ 3 Results ‣ CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments").
    Besides, the LLM planner can generate a customized list of tasks depending on
    the user’s meta-request. The state machines of the corresponding tasks are chained
    together as a bigger state machine to support the entire pipeline.'
  id: totrans-61
  prefs: []
  type: TYPE_NORMAL
  zh: '我们有4个预定义的元任务，支持4个基因编辑相关实验的完整流程；详见表格 [1](#S3.T1 "表1 ‣ 3.1.1 元模式 ‣ 3.1 CRISPR-GPT通过三个模块帮助研究人员进行基因编辑实验设计
    ‣ 3 结果 ‣ CRISPR-GPT: 一个用于自动化基因编辑实验设计的大型语言模型代理")。此外，LLM 规划器可以根据用户的元请求生成定制的任务列表。相应任务的状态机被链在一起，作为一个更大的状态机以支持整个流程。'
- en: Tool Provider connects Task Executor with external APIs
  id: totrans-62
  prefs:
  - PREF_H4
  type: TYPE_NORMAL
  zh: 工具提供者将任务执行器与外部 API 连接
- en: To connect language models with external functionalities [[1](#bib.bib1), [46](#bib.bib46),
    [49](#bib.bib49), [23](#bib.bib23), [37](#bib.bib37)], the system needs to (1)
    analyze the current situation and judge whether it’s suitable to call an external
    tool; (2) know what kinds of tools are available and choose the best from them.
    Instead of directly exposing the interfaces of the APIs to LLMs, in CRISPR-GPT,
    we wrap the usage of APIs inside the states and expose more user-friendly and
    LLM-friendly textual interfaces through hand-written instructions and responses.
    In plain words, we are teaching users (human agents & LLM agents) to use the tools.
    The tools include Google web search, running programs like Primer3 [[48](#bib.bib48)],
    as well as retrieval from external guide RNA libraries, research papers, and experiment
    protocols.
  id: totrans-63
  prefs: []
  type: TYPE_NORMAL
  zh: 为了将语言模型与外部功能连接起来 [[1](#bib.bib1), [46](#bib.bib46), [49](#bib.bib49), [23](#bib.bib23),
    [37](#bib.bib37)]，系统需要 (1) 分析当前情况并判断是否适合调用外部工具；(2) 了解有哪些工具可用并选择其中最合适的工具。在 CRISPR-GPT
    中，我们将 API 的使用封装在状态中，而不是直接暴露 API 的接口给 LLM，通过手动编写的指令和响应提供更友好且适合 LLM 的文本接口。简单来说，我们是在教用户（人类代理和
    LLM 代理）如何使用这些工具。这些工具包括 Google 网络搜索、运行程序如 Primer3 [[48](#bib.bib48)]，以及从外部引导 RNA
    库、研究论文和实验协议中检索信息。
- en: LLM-planner automatically generates a list of tasks based on the user’s request
  id: totrans-64
  prefs:
  - PREF_H4
  type: TYPE_NORMAL
  zh: LLM-planner 自动生成基于用户请求的任务列表。
- en: 'Large Language Models (LLMs) such as GPT-4 [[3](#bib.bib3)], Gemini [[47](#bib.bib47)],
    and Claude [[5](#bib.bib5)] can serve as the reasoning core of the LLM-powered
    agent to solve real-world decision-making problems. We adopt the popular ReAct [[53](#bib.bib53)]
    prompting technique, where the LLM is prompted to output the chain-of-thought [[50](#bib.bib50)]
    reasoning path and the final action from the plausible action set (Figure [3](#S2.F3
    "Figure 3 ‣ LLM-planner automatically generates a list of tasks based on the user’s
    request ‣ 2.1 Large Language Model ‣ 2 Methods and Algorithms ‣ CRISPR-GPT: An
    LLM Agent for Automated Design of Gene-Editing Experiments")). To let LLMs perform
    task decomposition [[54](#bib.bib54)], we provide a table of the descriptions
    and the dependencies of all the tasks as a prompt to the LLM. Based on LLM’s internal
    knowledge as well as our manually written descriptions of tasks and instruction
    of task decomposition, LLM can intelligently analyze the user’s request and decompose
    the user’s request into a sequence of tasks, respecting the dependencies of the
    tasks. After the decomposition, the corresponding state machines are chained together
    to complete all the tasks. The prompt format of the task decomposition can be
    found in Appendix [B](#A2 "Appendix B Prompt Formats ‣ CRISPR-GPT: An LLM Agent
    for Automated Design of Gene-Editing Experiments").'
  id: totrans-65
  prefs: []
  type: TYPE_NORMAL
  zh: '大型语言模型 (LLMs) 如 GPT-4 [[3](#bib.bib3)]、Gemini [[47](#bib.bib47)] 和 Claude [[5](#bib.bib5)]
    可以作为 LLM 驱动代理的推理核心，解决现实世界中的决策问题。我们采用流行的 ReAct [[53](#bib.bib53)] 提示技术，其中 LLM 被提示输出链式思维 [[50](#bib.bib50)]
    推理路径和从可能行动集合中得出的最终行动（图 [3](#S2.F3 "Figure 3 ‣ LLM-planner automatically generates
    a list of tasks based on the user’s request ‣ 2.1 Large Language Model ‣ 2 Methods
    and Algorithms ‣ CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing
    Experiments")）。为了让 LLM 执行任务分解 [[54](#bib.bib54)]，我们提供了一张任务描述和依赖关系的表格作为提示给 LLM。基于
    LLM 的内部知识以及我们手动编写的任务描述和任务分解指令，LLM 可以智能地分析用户的请求，并将其分解为一系列任务，尊重任务的依赖关系。分解后，相应的状态机被串联在一起以完成所有任务。任务分解的提示格式可以在附录 [B](#A2
    "Appendix B Prompt Formats ‣ CRISPR-GPT: An LLM Agent for Automated Design of
    Gene-Editing Experiments") 中找到。'
- en: '![Refer to caption](img/0fbd28f19478fe3ec16107bc9a6efbeb.png)'
  id: totrans-66
  prefs: []
  type: TYPE_IMG
  zh: '![参考说明](img/0fbd28f19478fe3ec16107bc9a6efbeb.png)'
- en: 'Figure 3: Task decomposition process and state machine implementation algorithm.
    (Left) Task decomposition; The LLMs can automatically perform task decomposition
    based on the user’s request, the descriptions of the current supported tasks and
    the dependencies, and the internal knowledge inside the LLMs. The state machines
    of the selected tasks are chained together to fulfill the user’s request. (Right)
    State machines & LLM Agent; State machines are the core of the Task Executor,
    where each state is responsible for one round of interaction with the user. The
    instruction is provided to the user first with sufficient information for the
    current decision-making step and the required inputs. After receiving the response
    from the user, it provides output and feedback, where APIs (e.g. program execution/web
    search/database retrieval) are potentially called during the execution of the
    state. Afterward, the state machine transits to the next state. LLM Agent generates
    responses to every step of the state machine on behalf of the user. The user monitors
    the whole process and provides corrections if the generated content is wrong or
    overrides the LLM Agent and manually interacts with the Task Executor.'
  id: totrans-67
  prefs: []
  type: TYPE_NORMAL
  zh: 图 3：任务分解过程和状态机实现算法。 （左）任务分解；LLMs 可以根据用户的请求、当前支持任务的描述和依赖关系以及 LLM 内部的知识自动执行任务分解。所选任务的状态机被串联在一起，以满足用户的请求。
    （右）状态机与 LLM Agent；状态机是任务执行器的核心，每个状态负责与用户进行一轮互动。首先向用户提供指令，包含当前决策步骤所需的充分信息和所需输入。在收到用户响应后，它提供输出和反馈，在执行状态期间可能会调用
    API（例如，程序执行/网络搜索/数据库检索）。之后，状态机过渡到下一个状态。LLM Agent 代表用户生成状态机每一步的响应。用户监控整个过程，并在生成的内容错误时进行纠正，或覆盖
    LLM Agent 并手动与任务执行器互动。
- en: For robustness, we do not allow LLMs to dynamically add/delete new tasks (new
    state machines) during the automatic execution. However, we believe this is an
    important step toward a more intelligent CRISPR-GPT version and leave this as
    future work.
  id: totrans-68
  prefs: []
  type: TYPE_NORMAL
  zh: 为了确保系统的稳健性，我们不允许 LLM 在自动执行过程中动态添加或删除新任务（新的状态机）。然而，我们认为这是朝着更智能的 CRISPR-GPT 版本迈进的重要一步，因此将其留作未来工作。
- en: LLM-Agent automatically interacts with the Task Executor based on the user’s
    meta request
  id: totrans-69
  prefs:
  - PREF_H4
  type: TYPE_NORMAL
  zh: LLM-Agent 根据用户的元请求自动与任务执行器进行互动。
- en: In addressing the complex challenge of automating CRISPR gene editing tasks,
    we conceptualize the problem through the lens of sequential decision-making. This
    perspective frames the interaction between the user and the automated system as
    a series of steps, each requiring precise decisions to progress towards the ultimate
    goal of experiment design and execution. Central to our system is the LLM-agent,
    which acts as an intermediary between the user and a state machine. This state
    machine is derived from an initial task decomposition step, effectively breaking
    down the gene editing process into a structured sequence of actions and decisions.
    At each step in this sequence, the state machine presents a current state to the
    LLM-agent. This state encapsulates a description of the task at hand and specifies
    any input required from the user to move forward.
  id: totrans-70
  prefs: []
  type: TYPE_NORMAL
  zh: 在解决自动化 CRISPR 基因编辑任务这一复杂挑战时，我们通过顺序决策的视角来构思问题。这一视角将用户与自动化系统之间的互动框架设定为一系列步骤，每一步都需要精确的决策，以实现实验设计和执行的终极目标。我们系统的核心是
    LLM-agent，它充当用户和状态机之间的中介。这个状态机源于初始任务分解步骤，有效地将基因编辑过程拆解为一个结构化的动作和决策序列。在序列中的每一步，状态机会向
    LLM-agent 展示当前状态。这个状态概括了当前任务的描述，并指定了用户向前推进所需的任何输入。
- en: 'The LLM-agent’s role is to interpret the current state and make informed decisions
    on behalf of the user. To do this effectively, the agent may draw upon a diverse
    set of information, including:'
  id: totrans-71
  prefs: []
  type: TYPE_NORMAL
  zh: LLM-agent 的角色是解释当前状态，并代表用户做出明智的决策。为了有效地完成这一任务，代理可能会借助各种信息，包括：
- en: •
  id: totrans-72
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: The instruction inherent to the current state,
  id: totrans-73
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 当前状态固有的指令，
- en: •
  id: totrans-74
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: The specific request made by the user,
  id: totrans-75
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 用户提出的具体请求，
- en: •
  id: totrans-76
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: A history of past interactions within the current task session,
  id: totrans-77
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 当前任务会话中的过去互动历史，
- en: •
  id: totrans-78
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: Results from external computational tools that have been integrated into the
    system.
  id: totrans-79
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 来自集成到系统中的外部计算工具的结果。
- en: 'This information is synthesized into a prompt for the LLM-agent, which then
    uses its capabilities to determine the most appropriate next action. The format
    and structure of these prompts, designed to optimize the decision-making process,
    are detailed in Appendix [B](#A2 "Appendix B Prompt Formats ‣ CRISPR-GPT: An LLM
    Agent for Automated Design of Gene-Editing Experiments").'
  id: totrans-80
  prefs: []
  type: TYPE_NORMAL
  zh: 这些信息被合成到LLM-agent的提示中，然后LLM-agent利用其能力确定最合适的下一步行动。这些提示的格式和结构旨在优化决策过程，详细内容见附录 [B](#A2
    "附录 B 提示格式 ‣ CRISPR-GPT：一种用于自动设计基因编辑实验的LLM代理")。
- en: User oversight is a critical component of this system. While the LLM-agent operates
    autonomously, the user is not removed from the process. Instead, they are encouraged
    to monitor the progression of tasks and interact with the agent. This setup ensures
    that any errors or misinterpretations by the LLM-agent can be quickly identified
    and corrected by the user, maintaining the accuracy and integrity of the gene
    editing experiment design. This approach to automation emphasizes a collaborative
    synergy between human expertise and artificial intelligence. By leveraging the
    LLM-agent’s ability to process and act on complex information, we facilitate a
    more efficient and user-friendly experience in designing CRISPR gene editing experiments.
    The sequential decision-making framework not only streamlines the task execution
    process but also ensures that user input remains a cornerstone of experiment planning
    and design.
  id: totrans-81
  prefs: []
  type: TYPE_NORMAL
  zh: 用户监督是该系统的关键组成部分。尽管LLM-agent自主操作，但用户并未被排除在外。相反，他们被鼓励监控任务进展并与代理互动。这种设置确保了LLM-agent的任何错误或误解都能被用户迅速识别和纠正，从而保持基因编辑实验设计的准确性和完整性。这种自动化方法强调了人类专业知识与人工智能之间的协作协同。通过利用LLM-agent处理和行动复杂信息的能力，我们在设计CRISPR基因编辑实验中提供了更高效和用户友好的体验。顺序决策框架不仅简化了任务执行过程，还确保了用户输入在实验规划和设计中的核心地位。
- en: 2.2 Human evaluation
  id: totrans-82
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 2.2 人工评估
- en: 'To evaluate the CRISPR-GPT agent’s effectiveness in aiding gene editing and
    experimental design, we assembled a diverse group of 12 experts in the field of
    CRISPR and gene editing research. Each of the 12 experts rated the responses to
    the experimental design tasks from three modes on a scale from 1 (Poor) to 5 (Excellent)
    according to the established criteria (all rubrics for the human evaluation are
    detailed in Appendix [C](#A3 "Appendix C The Rubrics for Human Evaluations ‣ CRISPR-GPT:
    An LLM Agent for Automated Design of Gene-Editing Experiments")). To offer a comparative
    perspective, outputs from both ChatGPT 3.5 and ChatGPT 4.0 (model version gpt-4-0613)
    were generated using similar prompts and evaluated using the same criteria.'
  id: totrans-83
  prefs: []
  type: TYPE_NORMAL
  zh: 为了评估CRISPR-GPT代理在辅助基因编辑和实验设计方面的有效性，我们组建了一个由12名CRISPR和基因编辑研究领域的专家组成的多样化小组。12名专家对三个模式下的实验设计任务的响应进行了评分，评分范围为1（差）到5（优秀），依据已建立的标准（所有人工评估的评分标准详见附录 [C](#A3
    "附录 C 人工评估评分标准 ‣ CRISPR-GPT：一种用于自动设计基因编辑实验的LLM代理")）。为了提供对比视角，使用类似提示生成了ChatGPT
    3.5和ChatGPT 4.0（模型版本gpt-4-0613）的输出，并使用相同标准进行了评估。
- en: 2.3 Biological experiment and wet-lab validation
  id: totrans-84
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 2.3 生物实验和湿实验验证
- en: We performed biological experiments through human-agent collaboration using
    CRISPR-GPT with ChatGPTv4 API, as wet-lab based real world validation of our approach.
    Specifically, we have independent scientist who are not familiar with gene-editing
    experiment to use CRISPR-GPT to facilitate their knock-out (KO) gene-editing experiments
    in a cancer research project. Detailed methods are provided below.
  id: totrans-85
  prefs: []
  type: TYPE_NORMAL
  zh: 我们通过人类与代理的协作，使用CRISPR-GPT和ChatGPTv4 API进行了生物实验，这是对我们方法的湿实验世界验证。具体而言，我们让不熟悉基因编辑实验的独立科学家使用CRISPR-GPT来促进他们在癌症研究项目中的基因敲除（KO）实验。详细方法见下文。
- en: Cell line and cell culture. A375 cell line was cultured in DMEM, high glucose,
    GlutaMAX (Gibco) supplemented with 10% fetal bovine serum (FBS, Gemini Bio), 100
    U/ml penicillin and 100ug/ml streptomycin (Gibco) at 37 ^∘C with 5% CO2.
  id: totrans-86
  prefs: []
  type: TYPE_NORMAL
  zh: 细胞系和细胞培养。A375细胞系在含有10%胎牛血清（FBS，Gemini Bio）、100 U/ml青霉素和100ug/ml链霉素（Gibco）的高葡萄糖DMEM、GlutaMAX（Gibco）中培养，在37
    ^∘C、5% CO2条件下培养。
- en: 'crRNA cloning. Cloning of 4 crRNAs (TGFBR1/SNAI1/BAX/BCL2L1) was performed
    with BbsI or Esp3I (NEB) through a Golden Gate assembly approach into a Cas12a
    expressing backbone backbone. Constructs were sequence verified by Sanger sequencing
    using a U6 sequencing primer: 5’-GACTATCATATGCTTACCGT-3’.'
  id: totrans-87
  prefs: []
  type: TYPE_NORMAL
  zh: crRNA克隆。使用BbsI或Esp3I（NEB）通过Golden Gate组装方法将4个crRNA（TGFBR1/SNAI1/BAX/BCL2L1）克隆到Cas12a表达的载体中。构建体通过使用U6测序引物5’-GACTATCATATGCTTACCGT-3’进行Sanger测序验证。
- en: Lentivirus packaging and transduction. Lentivirus was produced by co-transfecting
    the assembled lentiviral vector with VSV-G envelope and Delta-Vpr packaging plasmids
    into HEK-293T cells using PEI transfection reagent (Sigma-Aldrich). Supernatant
    was harvested 48 hr after transfection. A375 cells were transduced at low MOI
    with 8$\mathrm{\SIUnitSymbolMicro g}$/mL puromycin to establish stably expressing
    cell lines.
  id: totrans-88
  prefs: []
  type: TYPE_NORMAL
  zh: 慢病毒包装和转导。通过使用PEI转染试剂（Sigma-Aldrich）将组装好的慢病毒载体与VSV-G包膜和Delta-Vpr包装质粒共同转染到HEK-293T细胞中，生产慢病毒。转染后48小时收集上清液。A375细胞以低MOI与8$\mathrm{\SIUnitSymbolMicro
    g}$/mL的嘌呤霉素进行转导，以建立稳定表达的细胞系。
- en: gDNA extraction, PCR and sequencing. Genomic DNA was extracted from selected
    cells 7 days later using QuickExtract (Lucigen). The targeted loci were then amplified
    using Phusion Flash High-Fidelity PCR Master Mix (ThermoFisher Scientific) according
    to the manufacturer’s instructions with primers containing Illumina sequencing
    adapters. Paired-end reads (150 bp) were generated on an Illumina MiSeq platform.
  id: totrans-89
  prefs: []
  type: TYPE_NORMAL
  zh: gDNA提取、PCR和测序。选择的细胞在7天后使用QuickExtract（Lucigen）提取基因组DNA。然后使用Phusion Flash High-Fidelity
    PCR Master Mix（ThermoFisher Scientific）按照制造商的说明进行靶位点扩增，使用含Illumina测序适配器的引物。在Illumina
    MiSeq平台上生成配对末端读取（150 bp）。
- en: 3 Results
  id: totrans-90
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 3 结果
- en: CRISPR-GPT leverages the reasoning abilities of LLM, domain knowledge, retrieval
    techniques and external tools to provide a comprehensive solution to gene-editing
    experimental design tasks. It supports a wide arrange of gene editing scenarios,
    including single gene knockout, base editing without double strand breaks, insertions/deletions/replacement
    via prime editing, epigenetic editing for activation or repression of genes (CRISPRa
    and CRISPRi).
  id: totrans-91
  prefs: []
  type: TYPE_NORMAL
  zh: CRISPR-GPT利用LLM的推理能力、领域知识、检索技术和外部工具，为基因编辑实验设计任务提供全面解决方案。它支持广泛的基因编辑场景，包括单基因敲除、无双链断裂的碱基编辑、通过原位编辑进行的插入/删除/替换，以及基因的表观遗传编辑（CRISPRa和CRISPRi）。
- en: 3.1 CRISPR-GPT assists researchers with gene-editing experimental design through
    three modules.
  id: totrans-92
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 3.1 CRISPR-GPT通过三个模块协助研究人员进行基因编辑实验设计。
- en: 'The CRISPR-GPT agent aids researchers in designing gene-editing experiments
    via three distinct modules. ”Meta Mode” equips users, especially newcomers to
    the gene-editing field, with expertly defined pipelines for general gene editing
    scenarios (termed Meta-tasks). ”Auto Mode” automatically generates a tailored
    list of necessary design tasks based on user input, facilitating goal achievement
    for users of all experience levels. ”Q&A Mode” functions as an advanced GPT-4
    chatbot, addressing users’ CRISPR and gene-editing related queries throughout
    the design process (Figure [4](#S3.F4 "Figure 4 ‣ 3.1 CRISPR-GPT assists researchers
    with gene-editing experimental design through three modules. ‣ 3 Results ‣ CRISPR-GPT:
    An LLM Agent for Automated Design of Gene-Editing Experiments")).'
  id: totrans-93
  prefs: []
  type: TYPE_NORMAL
  zh: CRISPR-GPT代理通过三个不同的模块帮助研究人员设计基因编辑实验。“元模式”提供给用户，特别是基因编辑领域的新手，专家定义的管道用于一般基因编辑场景（称为Meta任务）。“自动模式”根据用户输入自动生成量身定制的设计任务列表，帮助所有经验水平的用户实现目标。“问答模式”作为高级GPT-4聊天机器人，在设计过程中解答用户的CRISPR和基因编辑相关问题（图[4](#S3.F4
    "图4 ‣ 3.1 CRISPR-GPT通过三个模块协助研究人员进行基因编辑实验设计 ‣ 3 结果 ‣ CRISPR-GPT：一种用于基因编辑实验自动化设计的LLM代理")）。
- en: '![Refer to caption](img/3f1c0241294b664db8f49e64359ccf5d.png)'
  id: totrans-94
  prefs: []
  type: TYPE_IMG
  zh: '![参见说明](img/3f1c0241294b664db8f49e64359ccf5d.png)'
- en: 'Figure 4: Overview of CRISPR-GPT’s interactive modules for gene-editing experimental
    design. (A) schematics illustrating the functionalities of the three modules within
    CRISPR-GPT, accompanied by examples of their applications. (B) Web-interface of
    CRISPR-GPT, note No.1-4 is the “Meta Mode”, No.5 is the “Auto Mode”, No.6 is Off-target-prediction
    function and “Q: prompt would trigger the Q&A mode”.'
  id: totrans-95
  prefs: []
  type: TYPE_NORMAL
  zh: 图4：CRISPR-GPT基因编辑实验设计的互动模块概览。（A）示意图展示了CRISPR-GPT中三个模块的功能，并附有它们应用的示例。（B）CRISPR-GPT的网页界面，注意第1-4项是“元模式”，第5项是“自动模式”，第6项是离靶预测功能，“Q:提示将触发问答模式”。
- en: 3.1.1 Meta Mode
  id: totrans-96
  prefs:
  - PREF_H4
  type: TYPE_NORMAL
  zh: 3.1.1 元模式
- en: '”Meta Mode” involves the planning and implementation of 22 unique gene-editing
    experimental design tasks utilizing four types of CRISPR-based gene editing systems
    (Meta-tasks) (Table [1](#S3.T1 "Table 1 ‣ 3.1.1 Meta Mode ‣ 3.1 CRISPR-GPT assists
    researchers with gene-editing experimental design through three modules. ‣ 3 Results
    ‣ CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments")).
    It leverages predefined pipelines to help users complete a Meta-task thoroughly.
    In this mode, the CRISPR-GPT agent guides users through each task necessary for
    designing gene editing experiments. This includes selecting the appropriate CRISPR
    system, recommending delivery methods, designing the sgRNA, predicting sgRNA off-target
    efficiency, selecting experimental protocols, and planning validation experiments.'
  id: totrans-97
  prefs: []
  type: TYPE_NORMAL
  zh: '“Meta Mode” 涉及规划和实施22项独特的基因编辑实验设计任务，利用四种CRISPR基础的基因编辑系统（Meta-tasks）（表格 [1](#S3.T1
    "Table 1 ‣ 3.1.1 Meta Mode ‣ 3.1 CRISPR-GPT assists researchers with gene-editing
    experimental design through three modules. ‣ 3 Results ‣ CRISPR-GPT: An LLM Agent
    for Automated Design of Gene-Editing Experiments")）。它利用预定义的流程帮助用户彻底完成一个Meta-task。在这种模式下，CRISPR-GPT代理引导用户完成设计基因编辑实验所需的每个任务。这包括选择合适的CRISPR系统、推荐交付方法、设计sgRNA、预测sgRNA的非目标效率、选择实验方案和规划验证实验。'
- en: 'For every design task, the CRISPR-GPT agent interacts with users, applying
    various techniques and external tools to deliver the optimal solution. For example,
    in choosing CRISPR systems, CRISPR-GPT continuously interacts with users, providing
    instructions and collecting information to suggest options based on published
    protocols (See example in Figure [5](#S3.F5 "Figure 5 ‣ 3.1.1 Meta Mode ‣ 3.1
    CRISPR-GPT assists researchers with gene-editing experimental design through three
    modules. ‣ 3 Results ‣ CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing
    Experiments") General Task 1). For context-sensitive tasks like delivery method
    recommendations, CRISPR-GPT not only suggests common methods but also offers customized
    solutions based on the user’s requests through web search (See example in Figure [5](#S3.F5
    "Figure 5 ‣ 3.1.1 Meta Mode ‣ 3.1 CRISPR-GPT assists researchers with gene-editing
    experimental design through three modules. ‣ 3 Results ‣ CRISPR-GPT: An LLM Agent
    for Automated Design of Gene-Editing Experiments") General Task 2). For sgRNA/pegRNA
    designs, a multi-species database derived from existing designs and publications
    enables CRISPR-GPT to swiftly suggest pre-designed sgRNA based on user information
    (See example in Figure [5](#S3.F5 "Figure 5 ‣ 3.1.1 Meta Mode ‣ 3.1 CRISPR-GPT
    assists researchers with gene-editing experimental design through three modules.
    ‣ 3 Results ‣ CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments")
    General Task 3). Following sgRNA/pegRNA design, users can evaluate designed guides’
    potential off-target effects with detailed instructions and code from CRISPR-GPT
    (See example in Figure [5](#S3.F5 "Figure 5 ‣ 3.1.1 Meta Mode ‣ 3.1 CRISPR-GPT
    assists researchers with gene-editing experimental design through three modules.
    ‣ 3 Results ‣ CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments")
    General Task 4). After completing design tasks, CRISPR-GPT offers selected protocols
    based on the interaction history, including CRISPR system selection and delivery
    methods (See example in Figure [5](#S3.F5 "Figure 5 ‣ 3.1.1 Meta Mode ‣ 3.1 CRISPR-GPT
    assists researchers with gene-editing experimental design through three modules.
    ‣ 3 Results ‣ CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments")
    General Task 5). Finally, for the validation task, CRISPR-GPT utilizes external
    APIs, like Primer3, to assist users in designing primers for validation experiments
    (See example in Figure [5](#S3.F5 "Figure 5 ‣ 3.1.1 Meta Mode ‣ 3.1 CRISPR-GPT
    assists researchers with gene-editing experimental design through three modules.
    ‣ 3 Results ‣ CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments")
    General Task 6).'
  id: totrans-98
  prefs: []
  type: TYPE_NORMAL
  zh: '对于每个设计任务，CRISPR-GPT 代理与用户互动，应用各种技术和外部工具以提供**最佳**解决方案。例如，在选择 CRISPR 系统时，CRISPR-GPT
    持续与用户互动，提供说明并收集信息，以根据已发布的协议建议选项（参见图 [5](#S3.F5 "Figure 5 ‣ 3.1.1 Meta Mode ‣ 3.1
    CRISPR-GPT assists researchers with gene-editing experimental design through three
    modules. ‣ 3 Results ‣ CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing
    Experiments") General Task 1）。对于上下文敏感的任务，如交付方法推荐，CRISPR-GPT 不仅建议常见方法，还根据用户的请求通过网络搜索提供定制的解决方案（参见图
    [5](#S3.F5 "Figure 5 ‣ 3.1.1 Meta Mode ‣ 3.1 CRISPR-GPT assists researchers with
    gene-editing experimental design through three modules. ‣ 3 Results ‣ CRISPR-GPT:
    An LLM Agent for Automated Design of Gene-Editing Experiments") General Task 2）。对于
    sgRNA/pegRNA 设计，基于现有设计和出版物的多物种数据库使 CRISPR-GPT 能够根据用户信息迅速建议预设计的 sgRNA（参见图 [5](#S3.F5
    "Figure 5 ‣ 3.1.1 Meta Mode ‣ 3.1 CRISPR-GPT assists researchers with gene-editing
    experimental design through three modules. ‣ 3 Results ‣ CRISPR-GPT: An LLM Agent
    for Automated Design of Gene-Editing Experiments") General Task 3）。在完成 sgRNA/pegRNA
    设计后，用户可以使用 CRISPR-GPT 提供的详细说明和代码评估设计引导的潜在脱靶效应（参见图 [5](#S3.F5 "Figure 5 ‣ 3.1.1
    Meta Mode ‣ 3.1 CRISPR-GPT assists researchers with gene-editing experimental
    design through three modules. ‣ 3 Results ‣ CRISPR-GPT: An LLM Agent for Automated
    Design of Gene-Editing Experiments") General Task 4）。完成设计任务后，CRISPR-GPT 根据互动历史提供选定的协议，包括
    CRISPR 系统选择和交付方法（参见图 [5](#S3.F5 "Figure 5 ‣ 3.1.1 Meta Mode ‣ 3.1 CRISPR-GPT assists
    researchers with gene-editing experimental design through three modules. ‣ 3 Results
    ‣ CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments")
    General Task 5）。最后，对于验证任务，CRISPR-GPT 利用外部 API，如 Primer3，帮助用户设计用于验证实验的引物（参见图 [5](#S3.F5
    "Figure 5 ‣ 3.1.1 Meta Mode ‣ 3.1 CRISPR-GPT assists researchers with gene-editing
    experimental design through three modules. ‣ 3 Results ‣ CRISPR-GPT: An LLM Agent
    for Automated Design of Gene-Editing Experiments") General Task 6）。'
- en: 'Table 1: List of meta-mode tasks (4 major meta-task and 22 specific tasks)'
  id: totrans-99
  prefs: []
  type: TYPE_NORMAL
  zh: 表 1：元模式任务列表（4 个主要元任务和 22 个具体任务）
- en: '| Meta-Tasks | Gene editing scenarios | Individual Design Tasks |'
  id: totrans-100
  prefs: []
  type: TYPE_TB
  zh: '| 元任务 | 基因编辑场景 | 个别设计任务 |'
- en: '| --- | --- | --- |'
  id: totrans-101
  prefs: []
  type: TYPE_TB
  zh: '| --- | --- | --- |'
- en: '| CRISPR Knockout | Single/multiple genes knockout, deletion of gene fragments
    | CRISPR/Cas system selection [[41](#bib.bib41)] |'
  id: totrans-102
  prefs: []
  type: TYPE_TB
  zh: '| CRISPR敲除 | 单/多基因敲除，基因片段删除 | CRISPR/Cas系统选择[[41](#bib.bib41)] |'
- en: '| Delivery method selection |'
  id: totrans-103
  prefs: []
  type: TYPE_TB
  zh: '| 交付方法选择 |'
- en: '| sgRNA design for knockout [[28](#bib.bib28), [14](#bib.bib14), [15](#bib.bib15),
    [43](#bib.bib43)] |'
  id: totrans-104
  prefs: []
  type: TYPE_TB
  zh: '| 用于敲除的sgRNA设计[[28](#bib.bib28), [14](#bib.bib14), [15](#bib.bib15), [43](#bib.bib43)]
    |'
- en: '| off-target evaluation [[11](#bib.bib11)] |'
  id: totrans-105
  prefs: []
  type: TYPE_TB
  zh: '| 离靶评估[[11](#bib.bib11)] |'
- en: '| experimental protocol recommendation [[21](#bib.bib21)] |'
  id: totrans-106
  prefs: []
  type: TYPE_TB
  zh: '| 实验协议推荐[[21](#bib.bib21)] |'
- en: '| validation protocol recommendation and primer design for sequencing [[48](#bib.bib48),
    [21](#bib.bib21)] |'
  id: totrans-107
  prefs: []
  type: TYPE_TB
  zh: '| 测序的验证协议推荐和引物设计[[48](#bib.bib48), [21](#bib.bib21)] |'
- en: '| CRISPR activation /interference | Gene activation and repression | CRISPR/Cas
    Activation/Interference system selection [[18](#bib.bib18)] |'
  id: totrans-108
  prefs: []
  type: TYPE_TB
  zh: '| CRISPR激活/干扰 | 基因激活和抑制 | CRISPR/Cas激活/干扰系统选择[[18](#bib.bib18)] |'
- en: '| Delivery method selection |'
  id: totrans-109
  prefs: []
  type: TYPE_TB
  zh: '| 交付方法选择 |'
- en: '| sgRNA design for activation/interference [[28](#bib.bib28), [14](#bib.bib14),
    [15](#bib.bib15), [43](#bib.bib43)] |'
  id: totrans-110
  prefs: []
  type: TYPE_TB
  zh: '| 激活/干扰的sgRNA设计[[28](#bib.bib28), [14](#bib.bib14), [15](#bib.bib15), [43](#bib.bib43)]
    |'
- en: '| off-target evaluation [[11](#bib.bib11)] |'
  id: totrans-111
  prefs: []
  type: TYPE_TB
  zh: '| 离靶评估[[11](#bib.bib11)] |'
- en: '| experimental protocol recommendation [[21](#bib.bib21)] |'
  id: totrans-112
  prefs: []
  type: TYPE_TB
  zh: '| 实验协议推荐[[21](#bib.bib21)] |'
- en: '| validation protocol recommendation and primer design for qPCR [[48](#bib.bib48),
    [21](#bib.bib21)] |'
  id: totrans-113
  prefs: []
  type: TYPE_TB
  zh: '| qPCR的验证协议推荐和引物设计[[48](#bib.bib48), [21](#bib.bib21)] |'
- en: '| CRISPR Base Editing | Single base replacement from CG to AT or AT to CG and
    broad mutagenesis | Base editing system selection [[26](#bib.bib26)] |'
  id: totrans-114
  prefs: []
  type: TYPE_TB
  zh: '| CRISPR基础编辑 | 单碱基替换从CG到AT或AT到CG以及广泛的突变 | 基础编辑系统选择[[26](#bib.bib26)] |'
- en: '| Delivery method selection |'
  id: totrans-115
  prefs: []
  type: TYPE_TB
  zh: '| 交付方法选择 |'
- en: '| sgRNA design for base editing [[22](#bib.bib22)] |'
  id: totrans-116
  prefs: []
  type: TYPE_TB
  zh: '| 基础编辑的sgRNA设计[[22](#bib.bib22)] |'
- en: '| off-target evaluation [[11](#bib.bib11)] |'
  id: totrans-117
  prefs: []
  type: TYPE_TB
  zh: '| 离靶评估[[11](#bib.bib11)] |'
- en: '| experimental protocol recommendation [[21](#bib.bib21)] |'
  id: totrans-118
  prefs: []
  type: TYPE_TB
  zh: '| 实验协议推荐[[21](#bib.bib21)] |'
- en: '| validation protocol recommendation and primer design for sequencing [[48](#bib.bib48),
    [21](#bib.bib21)] |'
  id: totrans-119
  prefs: []
  type: TYPE_TB
  zh: '| 测序的验证协议推荐和引物设计[[48](#bib.bib48), [21](#bib.bib21)] |'
- en: '| CRISPR Prime Editing | Small fragment insertion, replacement, and deletion
    | Prime editing system selection [[16](#bib.bib16)] |'
  id: totrans-120
  prefs: []
  type: TYPE_TB
  zh: '| CRISPR Prime Editing | 小片段插入、替换和删除 | Prime editing系统选择[[16](#bib.bib16)]
    |'
- en: '| Delivery method selection |'
  id: totrans-121
  prefs: []
  type: TYPE_TB
  zh: '| 交付方法选择 |'
- en: '| pegRNA design for prime editing[[8](#bib.bib8), [27](#bib.bib27), [12](#bib.bib12),
    [36](#bib.bib36)] |'
  id: totrans-122
  prefs: []
  type: TYPE_TB
  zh: '| 用于prime editing的pegRNA设计[[8](#bib.bib8), [27](#bib.bib27), [12](#bib.bib12),
    [36](#bib.bib36)] |'
- en: '| off-target evaluation [[11](#bib.bib11)] |'
  id: totrans-123
  prefs: []
  type: TYPE_TB
  zh: '| 离靶评估[[11](#bib.bib11)] |'
- en: '| experimental protocol recommendation [[21](#bib.bib21)] |'
  id: totrans-124
  prefs: []
  type: TYPE_TB
  zh: '| 实验协议推荐[[21](#bib.bib21)] |'
- en: '| validation protocol recommendation and primer design for sequencing [[48](#bib.bib48),
    [21](#bib.bib21)] |'
  id: totrans-125
  prefs: []
  type: TYPE_TB
  zh: '| 测序的验证协议推荐和引物设计[[48](#bib.bib48), [21](#bib.bib21)] |'
- en: '![Refer to caption](img/772fdbba398fd0468dcc24aaa1ff7b1c.png)'
  id: totrans-126
  prefs: []
  type: TYPE_IMG
  zh: '![参考说明](img/772fdbba398fd0468dcc24aaa1ff7b1c.png)'
- en: 'Figure 5: Example workflows outlining the general tasks involved in gene-editing
    experimental designs as facilitated by CRISPR-GPT.'
  id: totrans-127
  prefs: []
  type: TYPE_NORMAL
  zh: 图5：示例工作流程概述了CRISPR-GPT所促进的基因编辑实验设计中涉及的一般任务。
- en: 3.1.2 Auto Mode
  id: totrans-128
  prefs:
  - PREF_H4
  type: TYPE_NORMAL
  zh: 3.1.2 自动模式
- en: ”Auto Mode” also facilitates the planning and execution of 13 unique gene-editing
    experimental design tasks. Unlike ”Meta Mode,” it does not rely on predefined
    meta-tasks and pipelines; instead, it uses an LLM-planner to break down a user’s
    request into a sequence of dependent tasks. For instance, if a user requests to
    “design sgRNA to knockout human EGFR,” the CRISPR-GPT agent identifies the keywords
    from the request and lists the necessary design tasks, like “CRISPR/Cas system
    selection” and “sgRNA design for knockout.” Additionally, it uses information
    from the initial request (e.g., target gene “EGFR” and species “human”) to autofill
    relevant fields and generate sgRNA designs without needing repeated inputs from
    the user. Simultaneously, CRISPR-GPT elucidates the rationale behind its choices,
    allowing users to track the process and make corrections if necessary.
  id: totrans-129
  prefs: []
  type: TYPE_NORMAL
  zh: “自动模式”还促进了13项独特基因编辑实验设计任务的规划和执行。与“Meta模式”不同，它不依赖于预定义的元任务和管道；而是使用LLM规划器将用户的请求分解为一系列相关任务。例如，如果用户请求“设计sgRNA以敲除人类EGFR”，CRISPR-GPT代理会从请求中识别关键词，并列出必要的设计任务，如“CRISPR/Cas系统选择”和“敲除的sgRNA设计”。此外，它利用初始请求中的信息（例如，目标基因“EGFR”和物种“人类”）来自动填写相关字段并生成sgRNA设计，无需用户重复输入。同时，CRISPR-GPT阐明其选择背后的理由，使用户能够跟踪过程并在必要时进行修正。
- en: 3.1.3 Q&A Mode
  id: totrans-130
  prefs:
  - PREF_H4
  type: TYPE_NORMAL
  zh: 3.1.3 问答模式
- en: 'During the design tasks in ”Meta Mode” and ”Auto Mode,” the CRISPR-GPT agent
    offers immediate responses or advice for CRISPR and gene editing related inquiries
    through ”Q&A Mode.” For example, after selecting a CRISPR system, users seeking
    more information about the chosen system (e.g., Cas12a) can quickly obtain answers
    by asking, “Q: What is Cas12a?”. The CRISPR-GPT uses its knowledge base and document
    retrieval from expert-selected databases in the field to provide accurate and
    relevant information swiftly.'
  id: totrans-131
  prefs: []
  type: TYPE_NORMAL
  zh: '在“Meta Mode”和“Auto Mode”中的设计任务期间，CRISPR-GPT 代理通过“问答模式”提供有关 CRISPR 和基因编辑相关查询的即时响应或建议。例如，在选择了一个
    CRISPR 系统后，寻求有关所选系统（例如，Cas12a）更多信息的用户可以通过提问“Q: 什么是 Cas12a？”快速获得答案。CRISPR-GPT 利用其知识库和从领域专家选择的数据库中检索文档，以快速提供准确和相关的信息。'
- en: 3.2 CRISPR-GPT outperforms general LLMs in gene-editing design tasks through
    human expert evaluations.
  id: totrans-132
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 3.2 CRISPR-GPT 在基因编辑设计任务中的表现优于一般的大型语言模型（LLMs），这一点通过人工专家评估得到了验证。
- en: 'To evaluate the performance of CRISPR-GPT agent, we invited 12 researchers
    with expertise in CRISPR and gene editing to design sets of tasks to test the
    ability of CRISPR-GPT in assisting researchers with experimental design. The results
    are evaluated in four different aspects: Accuracy, Reasoning, Completeness and
    Conciseness (Appendix [C](#A3 "Appendix C The Rubrics for Human Evaluations ‣
    CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments")).
    Accuracy reflects whether CRISPR-GPT could provide accurate information of current
    state of CRISPR research and methodologies. Reasoning evaluates if CRISPR-GPT
    could provide insightful, well-supported explanation of the suggested designs.
    Completeness makes sure users receive all required information needed for CRISPR
    experimental design. Lastly, conciseness ensures that CRISPR-GPT provides users
    with directly relevant information for the design tasks with minimal unnecessary
    information. All evaluators were asked to score sets of tasks with these four
    aspects from 1 (Poor) to 5 (Excellent) for all three modes. Responses from ChatGPT
    3.5 and ChatGPT 4.0 were generated and scored alongside those of CRISPR-GPT, using
    equivalent prompts in all cases.'
  id: totrans-133
  prefs: []
  type: TYPE_NORMAL
  zh: 为了评估 CRISPR-GPT 代理的表现，我们邀请了 12 位在 CRISPR 和基因编辑方面具有专长的研究人员设计了一系列任务，以测试 CRISPR-GPT
    在协助研究人员进行实验设计方面的能力。结果在四个不同方面进行评估：准确性、推理、完整性和简洁性（附录 [C](#A3 "附录 C 人工评估评分标准 ‣ CRISPR-GPT：用于自动化基因编辑实验设计的
    LLM 代理")）。准确性反映了 CRISPR-GPT 是否能够提供关于当前 CRISPR 研究和方法的准确信息。推理评估 CRISPR-GPT 是否能够提供深入且有据可依的设计解释。完整性确保用户获得进行
    CRISPR 实验设计所需的所有信息。最后，简洁性确保 CRISPR-GPT 向用户提供与设计任务直接相关的信息，并尽量减少不必要的信息。所有评估者都被要求对三个模式下的任务集合从
    1（差）到 5（优）进行评分。ChatGPT 3.5 和 ChatGPT 4.0 的响应和评分与 CRISPR-GPT 一起生成和评分，所有情况下使用了等效的提示。
- en: '![Refer to caption](img/1b66a7a96f021d6d8ec34876a60be7c4.png)'
  id: totrans-134
  prefs: []
  type: TYPE_IMG
  zh: '![参见标题](img/1b66a7a96f021d6d8ec34876a60be7c4.png)'
- en: 'Figure 6: Evaluation results showing comparative performance of CRISPR-GPT
    and ChatGPT 3.5/4.0 in a range of gene-editing experiment design tasks across
    three different modes: MetaMode, AutoMode and QAMode. All tasks are scored in
    four different aspects: accuracy, reasoning, completeness, and conciseness. A
    score of 1 represents poor performance and 5 represents excellent performance.
    Detailed rubrics are listed in Appendix [C](#A3 "Appendix C The Rubrics for Human
    Evaluations ‣ CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments").'
  id: totrans-135
  prefs: []
  type: TYPE_NORMAL
  zh: 图 6：评估结果展示了 CRISPR-GPT 和 ChatGPT 3.5/4.0 在三种不同模式下的基因编辑实验设计任务的比较性能：MetaMode、AutoMode
    和 QAMode。所有任务在四个不同方面进行评分：准确性、推理、完整性和简洁性。评分为 1 表示表现差，5 表示表现优异。详细评分标准列在附录 [C](#A3
    "附录 C 人工评估评分标准 ‣ CRISPR-GPT：用于自动化基因编辑实验设计的 LLM 代理")。
- en: 'We observed that CRISPR-GPT achieved significantly higher accuracy in our designed
    sets of tasks over general LLM-agents across all three modes, as we employed vast
    domain knowledge in the CRISPR and gene editing field to ensure the robustness
    of the CRISPR-GPT agent (Figure [6](#S3.F6 "Figure 6 ‣ 3.2 CRISPR-GPT outperforms
    general LLMs in gene-editing design tasks through human expert evaluations. ‣
    3 Results ‣ CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments")).
    While, responses generated by general LLM agents including ChatGPT 3.5 and ChatGPT
    4.0 contain more minor factual errors due to known issues including inadequate
    domain knowledge and hallucination. At the same time, we found both CRISPR-GPT
    and general LLM agents show good reasoning ability over different sets of tasks.
    For “Auto Mode” related tasks, CRISPR-GPT showed even better reasoning, potentially
    due to better prompting techniques encoded in the agent. As we expected, “Completeness”
    is the major issue for general LLM-agents to perform gene-editing experimental
    design tasks. They can usually provide general guides for designs while could
    not provide design details due to the lack of domain knowledge and external tools.
    On the opposite side, CRISPR-GPT showed much better “Completeness” performance
    scores in the design tasks, allowing the users to perform the gene-editing experiment
    solely based on the information provided by CRISPR-GPT. It’s worth noting that
    both ChatGPT 3.5 and 4.0 outperform CRISPR-GPT in the “Completeness” performance
    score in “Q&A” mode. Such a result is due to the intentional tradeoff between
    “Completeness” and “Conciseness”. Answers directly generated by general LLM-agents
    usually include much irrelevant information in order to provide users with a more
    complete response. This usually confuses the users and makes it hard to catch
    the key information. In this case, we intentionally designed the CRISPR-GPT to
    provide concise accurate answers to the users across all different modes and accordingly
    CRISPR-GPT showed consistent better “Conciseness” performance scores.'
  id: totrans-136
  prefs: []
  type: TYPE_NORMAL
  zh: '我们观察到，CRISPR-GPT在我们设计的任务集中的准确性显著高于所有三种模式下的通用LLM代理，因为我们在CRISPR和基因编辑领域使用了大量领域知识，以确保CRISPR-GPT代理的稳健性（图[6](#S3.F6
    "Figure 6 ‣ 3.2 CRISPR-GPT outperforms general LLMs in gene-editing design tasks
    through human expert evaluations. ‣ 3 Results ‣ CRISPR-GPT: An LLM Agent for Automated
    Design of Gene-Editing Experiments")）。而通用LLM代理生成的响应，包括ChatGPT 3.5和ChatGPT 4.0，由于包括领域知识不足和幻觉等已知问题，包含更多的细微事实错误。同时，我们发现CRISPR-GPT和通用LLM代理在不同任务集上的推理能力都很好。对于“自动模式”相关的任务，CRISPR-GPT表现出更好的推理能力，这可能是由于代理中编码的更好的提示技术。正如我们预期的那样，“完整性”是通用LLM代理在执行基因编辑实验设计任务时的主要问题。它们通常可以提供设计的一般指南，但由于缺乏领域知识和外部工具，无法提供设计细节。相反，CRISPR-GPT在设计任务中表现出了更好的“完整性”得分，使用户可以仅根据CRISPR-GPT提供的信息进行基因编辑实验。值得注意的是，在“问答”模式下，ChatGPT
    3.5和4.0在“完整性”表现得分上超过了CRISPR-GPT。这种结果是由于“完整性”和“简洁性”之间的有意权衡。通用LLM代理直接生成的答案通常包含大量无关信息，以提供更完整的响应。这通常会使用户感到困惑，难以捕捉关键信息。在这种情况下，我们有意设计了CRISPR-GPT，以在所有不同模式下向用户提供简洁准确的答案，因此CRISPR-GPT表现出一致的更好“简洁性”得分。'
- en: Overall, through experts’ evaluation, we found CRISPR-GPT showed significantly
    improved performance over general LLM-agents for gene-editing experimental design
    tasks in all different aspects. Notwithstanding, CRISPR-GPT experienced difficulties
    in more complex gene editing scenarios and rare biological cases. It can be further
    extended and improved in the future with more up-to-date domain knowledge and
    better external tool sets.
  id: totrans-137
  prefs: []
  type: TYPE_NORMAL
  zh: 总体而言，通过专家评估，我们发现CRISPR-GPT在所有不同方面的基因编辑实验设计任务中表现显著优于通用LLM代理。然而，CRISPR-GPT在更复杂的基因编辑场景和稀有生物案例中遇到了困难。它可以在未来通过更新的领域知识和更好的外部工具集进一步扩展和改进。
- en: 3.3 CRISPR-GPT demonstrates its efficacy through real-world application.
  id: totrans-138
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 3.3 CRISPR-GPT通过真实世界应用展示了其有效性。
- en: 'To demonstrate CRISPR-GPT in assisting researchers with designing gene-editing
    experiments, we performed a gene knockout experiment in the human A375 cell line
    through continuous interaction with CRISPR-GPT (Figure [7](#S3.F7 "Figure 7 ‣
    3.3 CRISPR-GPT demonstrates its efficacy through real-world application. ‣ 3 Results
    ‣ CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments")).'
  id: totrans-139
  prefs: []
  type: TYPE_NORMAL
  zh: '为了展示CRISPR-GPT在辅助研究人员设计基因编辑实验中的作用，我们通过与CRISPR-GPT的持续互动，在人A375细胞系中进行了一项基因敲除实验（图 [7](#S3.F7
    "Figure 7 ‣ 3.3 CRISPR-GPT demonstrates its efficacy through real-world application.
    ‣ 3 Results ‣ CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments")）。'
- en: In this experiment, we aimed to knock out a panel of 4 genes (TGFBR1, SNAI1,
    BAX, BCL2L1) individually in the human A375 cell line. To start, we selected the
    “Meta mode” to design the gene knockout experiment from scratch. Following the
    instruction of selecting the CRISPR system in the CRISPR-GPT, we selected AsCas12a
    as we hope to perform multiple-site edits and lower the potential off-target editing
    rate. For the delivery of the CRISPR system in A375 cells, we followed CRISPR-GPT’s
    recommendation to use lentiviral transduction, ensuring stable expression of both
    the Cas enzyme and sgRNAs.
  id: totrans-140
  prefs: []
  type: TYPE_NORMAL
  zh: 在这项实验中，我们的目标是分别在人的A375细胞系中敲除4个基因（TGFBR1、SNAI1、BAX、BCL2L1）。首先，我们选择了“Meta模式”来从头设计基因敲除实验。根据CRISPR-GPT的指示，我们选择了AsCas12a，因为我们希望进行多位点编辑并降低潜在的脱靶编辑率。为了将CRISPR系统导入A375细胞，我们按照CRISPR-GPT的推荐使用了慢病毒转导，以确保Cas酶和sgRNA的稳定表达。
- en: 'Then, based on this information, we were able to obtain the Cas12a plasmid
    (previously owned). When it came to designing the sgRNAs, we specifically targeted
    the human TGFBR1/SNAI1/BAX/BCL2L1 genes, fully aware of the ethical ramifications
    of human gene editing raised by CRISPR-GPT. CRISPR-GPT provided 4 sgRNA sequences
    for each gene (Exampled in Figure [7](#S3.F7 "Figure 7 ‣ 3.3 CRISPR-GPT demonstrates
    its efficacy through real-world application. ‣ 3 Results ‣ CRISPR-GPT: An LLM
    Agent for Automated Design of Gene-Editing Experiments")) from a published library
    so we were able to order the sequences for synthesis.'
  id: totrans-141
  prefs: []
  type: TYPE_NORMAL
  zh: '然后，根据这些信息，我们能够获得Cas12a质粒（之前拥有）。在设计sgRNA时，我们专门针对人类TGFBR1/SNAI1/BAX/BCL2L1基因，充分了解CRISPR-GPT提出的人类基因编辑的伦理问题。CRISPR-GPT提供了每个基因的4个sgRNA序列（如图 [7](#S3.F7
    "Figure 7 ‣ 3.3 CRISPR-GPT demonstrates its efficacy through real-world application.
    ‣ 3 Results ‣ CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments")）来自一个已发布的库，因此我们能够订购这些序列进行合成。'
- en: '![Refer to caption](img/8e38286f66f6f16585111e7b507d2c12.png)'
  id: totrans-142
  prefs: []
  type: TYPE_IMG
  zh: '![参见说明](img/8e38286f66f6f16585111e7b507d2c12.png)'
- en: 'Figure 7: Wet-lab demonstration of human-AI collaboration in performing a gene-knockout
    experiment. (Left) Schematic showing the workflow of human-AI interaction. (Top
    right) Sample sgRNAs designed through CRISPR-GPT. (Bottom right) Editing outcome
    from next generation sequencing.'
  id: totrans-143
  prefs: []
  type: TYPE_NORMAL
  zh: 图7：人类与人工智能在执行基因敲除实验中的湿实验演示。（左）显示人类与人工智能互动工作流程的示意图。（右上）通过CRISPR-GPT设计的样本sgRNA。（右下）来自下一代测序的编辑结果。
- en: Later, CRISPR-GPT offered protocols for gRNA cloning. Detailed instructions
    were then provided for producing lentivirus through calcium phosphate transfection
    in HEK293T cells, using the necessary plasmids and viral packaging components.
    Following this, we exactly followed the protocol generated by CRISPR-GPT, through
    the transduction process, which involved cell culture procedures, the addition
    of lentivirus, and the use of polybrene to facilitate efficient transduction.
    To perform validation, we chose next-generation sequencing (NGS) for mutation
    detection and validation of the knockout in CRISPR-GPT, guided by the protocol
    provided by CRISPR-GPT agent. To prepare for NGS, we extracted genomic DNA from
    cells using the DNeasy Blood & Tissue Kit based on the protocols. For the crucial
    step of PCR primer design, we provided detailed sequence information to CRISPR-GPT,
    which automatically returned a set of primers designed with Primer3 to specifically
    amplify the target site. In the concluding stages of our experiment, CRISPR-GPT
    advised us to attach Illumina adaptors to the PCR products for library construction
    and emphasized the necessity of checking primer specificity with NCBI BLAST. This
    final validation step was crucial to prevent mis-priming and to ensure that the
    sequencing results would accurately reflect the intended genomic edits.
  id: totrans-144
  prefs: []
  type: TYPE_NORMAL
  zh: 随后，CRISPR-GPT提供了gRNA克隆的协议。然后提供了详细的指导，说明如何通过钙磷酸盐转染在HEK293T细胞中生产慢病毒，使用必要的质粒和病毒包装组件。之后，我们严格按照CRISPR-GPT生成的协议，通过转导过程，这包括细胞培养程序、添加慢病毒以及使用聚乙烯亚胺以促进有效的转导。为了进行验证，我们选择了下一代测序（NGS）来检测突变和验证CRISPR-GPT中的敲除，依据CRISPR-GPT代理提供的协议。为准备NGS，我们根据协议使用DNeasy
    Blood & Tissue Kit从细胞中提取基因组DNA。在PCR引物设计的关键步骤中，我们向CRISPR-GPT提供了详细的序列信息，CRISPR-GPT自动返回了一组使用Primer3设计的引物，以特异性扩增目标位点。在实验的最后阶段，CRISPR-GPT建议我们将Illumina适配子附加到PCR产物上进行文库构建，并强调了使用NCBI
    BLAST检查引物特异性的必要性。这一最终验证步骤对防止错误引物结合以及确保测序结果准确反映预期的基因组编辑至关重要。
- en: 'Finally, we analyzed the data from the NGS, and observed a consistent high
    rate of expected editing outcomes across all 4 targeted genes. Through this process,
    where CRISPR-GPT provided: (1) CRISPR system selection (2) guideRNA design (3)
    delivery system recommendation (4) plasmid and viral vector selection with cloning
    protocol (5) tissue culture, cell transduction procedures (6) cell harvesting
    and gene-editing efficiency quantification methods (7) sequencing primer design
    and readout validation protocol. Thus, the dynamic interaction between our expertise
    and CRISPR-GPT’s computational guidance was instrumental in executing a precise
    and ethically considerate gene-editing experiment.'
  id: totrans-145
  prefs: []
  type: TYPE_NORMAL
  zh: 最终，我们分析了来自NGS的数据，并观察到所有4个目标基因中预期编辑结果的一致高频率。通过这个过程，CRISPR-GPT提供了：(1) CRISPR系统选择
    (2) guideRNA设计 (3) 递送系统推荐 (4) 质粒和病毒载体选择及克隆协议 (5) 组织培养、细胞转导程序 (6) 细胞收获和基因编辑效率定量方法
    (7) 测序引物设计和读数验证协议。因此，我们的专业知识与CRISPR-GPT的计算指导之间的动态互动对执行精确且伦理考虑周到的基因编辑实验至关重要。
- en: 4 Safety and Ethical Concerns
  id: totrans-146
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 4 安全与伦理问题
- en: Safety and ethical concerns arise when using AI tools to guide genome editing,
    ranging from the risk of illegally altering human genomes to privacy issues when
    user genome information is involved.
  id: totrans-147
  prefs: []
  type: TYPE_NORMAL
  zh: 使用AI工具指导基因组编辑时会出现安全和伦理问题，这些问题包括非法改变人类基因组的风险以及涉及用户基因组信息时的隐私问题。
- en: 4.1 Mitigation of the risk of human heritable editing
  id: totrans-148
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 4.1 降低人类遗传编辑风险
- en: Technologies such as CRISPR-Cas9, have made it possible to alter human genomes,
    which pose a number of ethical and safety risks. In particular, germline cell
    and embryo genome editing bring up a number of ethical challenges, including whether
    it would be permissible to use this technology to enhance normal human traits
    (such as height or intelligence). Based on concerns about ethics and safety, germline
    cell and embryo genome editing are currently illegal in the United States and
    many other countries. To ensure CRISPR-GPT follows the guidelines given in a moratorium [[30](#bib.bib30)]
    on heritable genome editing.
  id: totrans-149
  prefs: []
  type: TYPE_NORMAL
  zh: CRISPR-Cas9等技术使得改变人类基因组成为可能，这带来了一系列伦理和安全风险。特别是，生殖系细胞和胚胎基因组编辑提出了许多伦理挑战，包括是否允许使用这些技术来增强正常的人类特征（如身高或智力）。基于对伦理和安全的担忧，目前在美国和许多其他国家，生殖系细胞和胚胎基因组编辑是非法的。为确保CRISPR-GPT遵循关于遗传基因组编辑的暂停指南[[30](#bib.bib30)]。
- en: 'CRISPR-GPT employs a mechanism to make sure in all tasks users cannot bypass
    the existing step asking which organism they are editing. The agent would check
    if the editing target belonged to human tissues or organs. If it is found that
    the editing target is a human organ, it will trigger the following solution: Warning
    note when users proceed with designing human gene-editing exp. Link to this international
    moratorium with note. Ask users to confirm they understand the risk and have read
    this international guideline before proceeding.'
  id: totrans-150
  prefs: []
  type: TYPE_NORMAL
  zh: CRISPR-GPT采用了一种机制，确保用户在所有任务中无法绕过要求其编辑的生物体步骤。该代理将检查编辑目标是否属于人类组织或器官。如果发现编辑目标是人类器官，它将触发以下解决方案：当用户继续设计人类基因编辑实验时发出警告。链接到国际暂停令并附上说明。要求用户确认他们了解风险并已阅读该国际指南后再继续操作。
- en: 4.2 Protection of user genome data privacy
  id: totrans-151
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: 4.2 用户基因组数据隐私保护
- en: 'Other concerns are related to user data privacy issues, especially when human
    genome sequence information might be exchanged by using AI tools. We follow the
    data privacy and HIPAA privacy rule in healthcare [[2](#bib.bib2)]. Although genome-scale
    sequences are fundamentally linked to identities, DNA segments of up to 20 bp
    length are considered safe and not able to identify human identity (REF). CPISPR-GPT
    is equipped with the following functionalities, to avoid supplying any identifiable
    private human/patient sequence to a public LLM model. Specifically, our solution
    is:'
  id: totrans-152
  prefs: []
  type: TYPE_NORMAL
  zh: 其他问题与用户数据隐私有关，尤其是在使用AI工具交换人类基因组序列信息时。我们遵循数据隐私和医疗保健中的HIPAA隐私规则[[2](#bib.bib2)]。尽管基因组规模的序列与身份本质上相关，但长度达到20
    bp的DNA片段被认为是安全的，无法识别个人身份（参考）。CRISPR-GPT配备了以下功能，以避免向公共LLM模型提供任何可识别的私人/患者序列。具体来说，我们的解决方案是：
- en: •
  id: totrans-153
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: CRISPR-GPT would never store any identifiable long genome sequence in the server
    that would potentially reveal patient private information.
  id: totrans-154
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: CRISPR-GPT绝不会在服务器上存储任何可能泄露患者私人信息的可识别长基因组序列。
- en: •
  id: totrans-155
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: CRISPR-GPT implements a filter to detect if there is any $\geq$ 20bp of A/T/G/C/U
    sequence contained in the prompts before sending them to external LLMs. After
    detecting the existence of such a sequence, the agent would raise an error with
    a warning note, asking the user to manually delete such sequences in the input.
    In this way, it avoids leaking such sensitive information to the public LLM model.
  id: totrans-156
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: CRISPR-GPT实施了一种过滤器，以检测提示中是否包含任何$\geq$ 20bp的A/T/G/C/U序列，然后再将其发送给外部LLMs。在检测到这种序列的存在后，代理将引发错误并发出警告，要求用户手动删除输入中的这种序列。通过这种方式，避免将此类敏感信息泄露给公共LLM模型。
- en: 5 Discussion
  id: totrans-157
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 5 讨论
- en: The CRISPR-GPT agent showcases the remarkable potential of LLMs in automating
    and enhancing the design process of complex biological experiments. By seamlessly
    integrating LLMs with domain knowledge, external tools, and a modular task execution
    system, CRISPR-GPT empowers researchers to navigate the intricate landscape of
    CRISPR gene editing experiments with unprecedented ease and efficiency. The multi-modal
    capabilities of CRISPR-GPT encompass meta-task pipelines, interactive prompts,
    and on-demand Q&A support. Researchers can leverage the agent’s expertise to plan
    and execute gene editing experiments, from CRISPR system selection and guide RNA
    design to automated drafting of detailed protocol and validation strategies. This
    streamlined workflow not only accelerates the design process but also mitigates
    the risk of errors and oversights, thereby enhancing the quality and reproducibility
    of research outcomes.
  id: totrans-158
  prefs: []
  type: TYPE_NORMAL
  zh: CRISPR-GPT展示了LLMs在自动化和增强复杂生物实验设计过程中的卓越潜力。通过无缝集成LLMs与领域知识、外部工具和模块化任务执行系统，CRISPR-GPT使研究人员能够以前所未有的轻松和高效的方式导航CRISPR基因编辑实验的复杂领域。CRISPR-GPT的多模态能力包括元任务管道、交互式提示和按需问答支持。研究人员可以利用该代理的专业知识来规划和执行基因编辑实验，从CRISPR系统选择和引导RNA设计到自动起草详细的方案和验证策略。这种简化的工作流程不仅加快了设计过程，还减少了错误和遗漏的风险，从而提高了研究结果的质量和重复性。
- en: While there exist LLM agent in other scientific domains such as chemistry, the
    complexities of biological experiments involving living materials demand a distinct
    set of considerations. Unlike chemical reactions, which often follow well-defined
    protocols, biological experiments require intricate procedures that account for
    the dynamic nature of living systems. CRISPR-GPT addresses this challenge by providing
    detailed, step-by-step guidance tailored to the specific experimental context,
    ensuring that researchers can navigate the nuances of working with living cells
    and organisms effectively.
  id: totrans-159
  prefs: []
  type: TYPE_NORMAL
  zh: 尽管在化学等其他科学领域存在 LLM 代理，但涉及活体材料的生物实验的复杂性要求有一套不同的考虑因素。与通常遵循明确程序的化学反应不同，生物实验需要复杂的程序来考虑生物系统的动态特性。CRISPR-GPT
    通过提供详细的、逐步的指导来应对这一挑战，这些指导根据具体实验环境量身定制，确保研究人员能够有效地处理与活细胞和生物体打交道的细微差别。
- en: Moreover, the free-style prompting and ad hoc Q&A capabilities of CRISPR-GPT
    set it apart from many existing agents. Researchers can pose unstructured queries
    and receive contextualized responses, facilitating a more natural and intuitive
    interaction with the agent. This feature is valuable in the face of unexpected
    challenges or unforeseen circumstances that may arise during the course of an
    experiment, enabling researchers to seek timely guidance and adapt their approach
    as needed.
  id: totrans-160
  prefs: []
  type: TYPE_NORMAL
  zh: 此外，CRISPR-GPT 的自由风格提示和即兴问答能力使其与许多现有代理不同。研究人员可以提出无结构的查询，并获得上下文化的回应，从而促进与代理的更加自然和直观的互动。这一特点在面对实验过程中可能出现的意外挑战或突发情况时尤为宝贵，使研究人员能够及时寻求指导，并根据需要调整他们的方法。
- en: Despite its impressive capabilities, CRISPR-GPT is not without limitations.
    While the agent can design individual components, such as guide RNAs and primers,
    it currently lacks the ability to generate complete constructs or vectors from
    natural language input. This limitation highlights an area for future development.
    For example, recent advancements in the field of modular design of gene-editing,
    such as FragMID [[35](#bib.bib35)] could be integrated with CRISPR-GPT to realize
    the potential for LLMs to empower researchers to explore and optimize CRISPR design
    and customized strategies, leading to more efficient gene-editing.
  id: totrans-161
  prefs: []
  type: TYPE_NORMAL
  zh: 尽管具有令人印象深刻的能力，CRISPR-GPT 也存在一定的局限性。虽然该代理能够设计单个组件，如导向 RNA 和引物，但目前尚缺乏从自然语言输入生成完整构造体或载体的能力。这一局限性突显了未来发展的一个方向。例如，基因编辑的模块化设计领域的最新进展，如
    FragMID [[35](#bib.bib35)]，可以与 CRISPR-GPT 集成，以实现大型语言模型（LLMs）赋能研究人员探索和优化 CRISPR
    设计及定制策略，从而实现更高效的基因编辑。
- en: Looking ahead, the integration of CRISPR-GPT with automated laboratory platforms
    and robotics holds immense promise. By bridging computational design and physical
    execution, researchers could leverage the agent’s expertise to orchestrate end-to-end
    automated experiments, minimizing manual intervention and accelerating the pace
    of discovery.
  id: totrans-162
  prefs: []
  type: TYPE_NORMAL
  zh: 展望未来，CRISPR-GPT 与自动化实验室平台和机器人技术的结合前景广阔。通过弥合计算设计和物理执行，研究人员可以利用代理的专业知识来协调端到端的自动化实验，减少人工干预，加快发现的步伐。
- en: References
  id: totrans-163
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 参考文献
- en: '[1] Chatgpt plugins. [https://openai.com/blog/chatgpt-plugins](https://openai.com/blog/chatgpt-plugins).'
  id: totrans-164
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[1] Chatgpt 插件。 [https://openai.com/blog/chatgpt-plugins](https://openai.com/blog/chatgpt-plugins)。'
- en: '[2] Rights (ocr), o. for c. summary of the hipaa privacy rule. [https://www.hhs.gov/hipaa/for-professionals/privacy/laws-regulations/index.html](https://www.hhs.gov/hipaa/for-professionals/privacy/laws-regulations/index.html),
    2008.'
  id: totrans-165
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[2] 权利（ocr），o. 对 c. hipaa 隐私规则摘要。 [https://www.hhs.gov/hipaa/for-professionals/privacy/laws-regulations/index.html](https://www.hhs.gov/hipaa/for-professionals/privacy/laws-regulations/index.html)，2008年。'
- en: '[3] Josh Achiam, Steven Adler, Sandhini Agarwal, Lama Ahmad, Ilge Akkaya, Florencia Leoni
    Aleman, Diogo Almeida, Janko Altenschmidt, Sam Altman, Shyamal Anadkat, et al.
    Gpt-4 technical report. arXiv preprint arXiv:2303.08774, 2023.'
  id: totrans-166
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[3] Josh Achiam, Steven Adler, Sandhini Agarwal, Lama Ahmad, Ilge Akkaya, Florencia
    Leoni Aleman, Diogo Almeida, Janko Altenschmidt, Sam Altman, Shyamal Anadkat 等。GPT-4
    技术报告。arXiv 预印本 arXiv:2303.08774，2023年。'
- en: '[4] Rohan Anil, Andrew M Dai, Orhan Firat, Melvin Johnson, Dmitry Lepikhin,
    Alexandre Passos, Siamak Shakeri, Emanuel Taropa, Paige Bailey, Zhifeng Chen,
    et al. Palm 2 technical report. arXiv preprint arXiv:2305.10403, 2023.'
  id: totrans-167
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[4] Rohan Anil, Andrew M Dai, Orhan Firat, Melvin Johnson, Dmitry Lepikhin,
    Alexandre Passos, Siamak Shakeri, Emanuel Taropa, Paige Bailey, Zhifeng Chen 等。Palm
    2 技术报告。arXiv 预印本 arXiv:2305.10403，2023年。'
- en: '[5] Anthropic. Claude 3 model card. [https://www.anthropic.com/claude-3-model-card](https://www.anthropic.com/claude-3-model-card).'
  id: totrans-168
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[5] Anthropic。Claude 3 模型卡。 [https://www.anthropic.com/claude-3-model-card](https://www.anthropic.com/claude-3-model-card)。'
- en: '[6] Andrew V Anzalone, Luke W Koblan, and David R Liu. Genome editing with
    crispr–cas nucleases, base editors, transposases and prime editors. Nature biotechnology,
    38(7):824–844, 2020.'
  id: totrans-169
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[6] Andrew V Anzalone, Luke W Koblan, 和 David R Liu. 使用 crispr–cas 核酸酶、碱基编辑器、转座酶和
    prime 编辑器进行基因组编辑。自然生物技术, 38(7):824–844, 2020。'
- en: '[7] Andrew V Anzalone, Peyton B Randolph, Jessie R Davis, Alexander A Sousa,
    Luke W Koblan, Jonathan M Levy, Peter J Chen, Christopher Wilson, Gregory A Newby,
    Aditya Raguram, et al. Search-and-replace genome editing without double-strand
    breaks or donor dna. Nature, 576(7785):149–157, 2019.'
  id: totrans-170
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[7] Andrew V Anzalone, Peyton B Randolph, Jessie R Davis, Alexander A Sousa,
    Luke W Koblan, Jonathan M Levy, Peter J Chen, Christopher Wilson, Gregory A Newby,
    Aditya Raguram 等. 无需双链断裂或供体 DNA 的搜索与替换基因组编辑。自然, 576(7785):149–157, 2019。'
- en: '[8] Daniil A Boiko, Robert MacKnight, Ben Kline, and Gabe Gomes. Autonomous
    chemical research with large language models. Nature, 624(7992):570–578, 2023.'
  id: totrans-171
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[8] Daniil A Boiko, Robert MacKnight, Ben Kline, 和 Gabe Gomes. 使用大型语言模型的自主化化学研究。自然,
    624(7992):570–578, 2023。'
- en: '[9] Andres M Bran, Sam Cox, Oliver Schilter, Carlo Baldassari, Andrew D White,
    and Philippe Schwaller. Chemcrow: Augmenting large-language models with chemistry
    tools. arXiv preprint arXiv:2304.05376, 2023.'
  id: totrans-172
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[9] Andres M Bran, Sam Cox, Oliver Schilter, Carlo Baldassari, Andrew D White,
    和 Philippe Schwaller. Chemcrow: 使用化学工具增强大型语言模型。arXiv 预印本 arXiv:2304.05376, 2023。'
- en: '[10] Tianle Cai, Xuezhi Wang, Tengyu Ma, Xinyun Chen, and Denny Zhou. Large
    language models as tool makers. arXiv preprint arXiv:2305.17126, 2023.'
  id: totrans-173
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[10] Tianle Cai, Xuezhi Wang, Tengyu Ma, Xinyun Chen, 和 Denny Zhou. 大型语言模型作为工具制造者。arXiv
    预印本 arXiv:2305.17126, 2023。'
- en: '[11] Samuele Cancellieri, Matthew C Canver, Nicola Bombieri, Rosalba Giugno,
    and Luca Pinello. Crispritz: rapid, high-throughput and variant-aware in silico
    off-target site identification for crispr genome editing. Bioinformatics, 36(7):2001–2008,
    2020.'
  id: totrans-174
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[11] Samuele Cancellieri, Matthew C Canver, Nicola Bombieri, Rosalba Giugno,
    和 Luca Pinello. Crispritz: 快速、高通量且变体感知的计算离靶位点识别，用于 crispr 基因组编辑。生物信息学, 36(7):2001–2008,
    2020。'
- en: '[12] Ryan D Chow, Jennifer S Chen, Johanna Shen, and Sidi Chen. A web tool
    for the design of prime-editing guide rnas. Nature biomedical engineering, 5(2):190–194,
    2021.'
  id: totrans-175
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[12] Ryan D Chow, Jennifer S Chen, Johanna Shen, 和 Sidi Chen. 用于设计 prime-editing
    引导 RNA 的网页工具。自然生物医学工程, 5(2):190–194, 2021。'
- en: '[13] Aakanksha Chowdhery, Sharan Narang, Jacob Devlin, Maarten Bosma, Gaurav
    Mishra, Adam Roberts, Paul Barham, Hyung Won Chung, Charles Sutton, Sebastian
    Gehrmann, et al. Palm: Scaling language modeling with pathways. Journal of Machine
    Learning Research, 24(240):1–113, 2023.'
  id: totrans-176
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[13] Aakanksha Chowdhery, Sharan Narang, Jacob Devlin, Maarten Bosma, Gaurav
    Mishra, Adam Roberts, Paul Barham, Hyung Won Chung, Charles Sutton, Sebastian
    Gehrmann 等. Palm: 使用路径扩展语言建模。机器学习研究杂志, 24(240):1–113, 2023。'
- en: '[14] Peter C DeWeirdt, Kendall R Sanson, Annabel K Sangree, Mudra Hegde, Ruth E
    Hanna, Marissa N Feeley, Audrey L Griffith, Teng Teng, Samantha M Borys, Christine
    Strand, et al. Optimization of ascas12a for combinatorial genetic screens in human
    cells. Nature biotechnology, 39(1):94–104, 2021.'
  id: totrans-177
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[14] Peter C DeWeirdt, Kendall R Sanson, Annabel K Sangree, Mudra Hegde, Ruth
    E Hanna, Marissa N Feeley, Audrey L Griffith, Teng Teng, Samantha M Borys, Christine
    Strand 等. 优化 ascas12a 以用于人类细胞的组合遗传筛选。自然生物技术, 39(1):94–104, 2021。'
- en: '[15] John G Doench, Nicolo Fusi, Meagan Sullender, Mudra Hegde, Emma W Vaimberg,
    Katherine F Donovan, Ian Smith, Zuzana Tothova, Craig Wilen, Robert Orchard, et al.
    Optimized sgrna design to maximize activity and minimize off-target effects of
    crispr-cas9. Nature biotechnology, 34(2):184–191, 2016.'
  id: totrans-178
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[15] John G Doench, Nicolo Fusi, Meagan Sullender, Mudra Hegde, Emma W Vaimberg,
    Katherine F Donovan, Ian Smith, Zuzana Tothova, Craig Wilen, Robert Orchard 等.
    优化的 sgrna 设计以最大化活性和最小化 crispr-cas9 的离靶效应。自然生物技术, 34(2):184–191, 2016。'
- en: '[16] Jordan L Doman, Alexander A Sousa, Peyton B Randolph, Peter J Chen, and
    David R Liu. Designing and executing prime editing experiments in mammalian cells.
    Nature protocols, 17(11):2431–2468, 2022.'
  id: totrans-179
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[16] Jordan L Doman, Alexander A Sousa, Peyton B Randolph, Peter J Chen, 和
    David R Liu. 在哺乳动物细胞中设计和执行 prime editing 实验。自然协议, 17(11):2431–2468, 2022。'
- en: '[17] Jennifer A Doudna and Emmanuelle Charpentier. The new frontier of genome
    engineering with crispr-cas9. Science, 346(6213):1258096, 2014.'
  id: totrans-180
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[17] Jennifer A Doudna 和 Emmanuelle Charpentier. 以 crispr-cas9 进行基因组工程的新前沿。科学,
    346(6213):1258096, 2014。'
- en: '[18] Dan Du and Lei S Qi. Crispr technology for genome activation and repression
    in mammalian cells. Cold Spring Harbor Protocols, 2016(1):pdb–prot090175, 2016.'
  id: totrans-181
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[18] Dan Du 和 Lei S Qi. Crispr 技术在哺乳动物细胞中的基因组激活和抑制。Cold Spring Harbor 协议, 2016(1):pdb–prot090175,
    2016。'
- en: '[19] Nicole M Gaudelli, Alexis C Komor, Holly A Rees, Michael S Packer, Ahmed H
    Badran, David I Bryson, and David R Liu. Programmable base editing of a• t to
    g• c in genomic dna without dna cleavage. Nature, 551(7681):464–471, 2017.'
  id: totrans-182
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[19] Nicole M Gaudelli, Alexis C Komor, Holly A Rees, Michael S Packer, Ahmed
    H Badran, David I Bryson 和 David R Liu. 在基因组DNA中进行可编程碱基编辑，将A•T编辑为G•C，无需DNA切割。《Nature》，551(7681):464–471,
    2017。'
- en: '[20] Luke A Gilbert, Matthew H Larson, Leonardo Morsut, Zairan Liu, Gloria A
    Brar, Sandra E Torres, Noam Stern-Ginossar, Onn Brandman, Evan H Whitehead, Jennifer A
    Doudna, et al. Crispr-mediated modular rna-guided regulation of transcription
    in eukaryotes. Cell, 154(2):442–451, 2013.'
  id: totrans-183
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[20] Luke A Gilbert, Matthew H Larson, Leonardo Morsut, Zairan Liu, Gloria
    A Brar, Sandra E Torres, Noam Stern-Ginossar, Onn Brandman, Evan H Whitehead,
    Jennifer A Doudna 等. CRISPR介导的模块化RNA引导转录调控在真核生物中的应用。《Cell》，154(2):442–451, 2013。'
- en: '[21] Christopher J Giuliano, Ann Lin, Vishruth Girish, and Jason M Sheltzer.
    Generating single cell–derived knockout clones in mammalian cells with crispr/cas9.
    Current protocols in molecular biology, 128(1):e100, 2019.'
  id: totrans-184
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[21] Christopher J Giuliano, Ann Lin, Vishruth Girish 和 Jason M Sheltzer. 在哺乳动物细胞中生成单细胞衍生的敲除克隆，使用CRISPR/Cas9。《Current
    Protocols in Molecular Biology》，128(1):e100, 2019。'
- en: '[22] Ruth E Hanna, Mudra Hegde, Christian R Fagre, Peter C DeWeirdt, Annabel K
    Sangree, Zsofia Szegletes, Audrey Griffith, Marissa N Feeley, Kendall R Sanson,
    Yossef Baidi, et al. Massively parallel assessment of human variants with base
    editor screens. Cell, 184(4):1064–1080, 2021.'
  id: totrans-185
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[22] Ruth E Hanna, Mudra Hegde, Christian R Fagre, Peter C DeWeirdt, Annabel
    K Sangree, Zsofia Szegletes, Audrey Griffith, Marissa N Feeley, Kendall R Sanson,
    Yossef Baidi 等. 大规模平行评估人类变异的碱基编辑器筛选。《Cell》，184(4):1064–1080, 2021。'
- en: '[23] Shibo Hao, Tianyang Liu, Zhen Wang, and Zhiting Hu. Toolkengpt: Augmenting
    frozen language models with massive tools via tool embeddings. Advances in neural
    information processing systems, 36, 2024.'
  id: totrans-186
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[23] Shibo Hao, Tianyang Liu, Zhen Wang 和 Zhiting Hu. Toolkengpt：通过工具嵌入增强冻结语言模型的能力。《Advances
    in Neural Information Processing Systems》，36, 2024。'
- en: '[24] Jordan Hoffmann, Sebastian Borgeaud, Arthur Mensch, Elena Buchatskaya,
    Trevor Cai, Eliza Rutherford, Diego de Las Casas, Lisa Anne Hendricks, Johannes
    Welbl, Aidan Clark, et al. Training compute-optimal large language models. arXiv
    preprint arXiv:2203.15556, 2022.'
  id: totrans-187
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[24] Jordan Hoffmann, Sebastian Borgeaud, Arthur Mensch, Elena Buchatskaya,
    Trevor Cai, Eliza Rutherford, Diego de Las Casas, Lisa Anne Hendricks, Johannes
    Welbl, Aidan Clark 等. 训练计算最优的大型语言模型。arXiv预印本 arXiv:2203.15556, 2022。'
- en: '[25] Patrick D Hsu, Eric S Lander, and Feng Zhang. Development and applications
    of crispr-cas9 for genome engineering. Cell, 157(6):1262–1278, 2014.'
  id: totrans-188
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[25] Patrick D Hsu, Eric S Lander 和 Feng Zhang. CRISPR-Cas9在基因组工程中的发展和应用。《Cell》，157(6):1262–1278,
    2014。'
- en: '[26] Tony P Huang, Gregory A Newby, and David R Liu. Precision genome editing
    using cytosine and adenine base editors in mammalian cells. Nature protocols,
    16(2):1089–1128, 2021.'
  id: totrans-189
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[26] Tony P Huang, Gregory A Newby 和 David R Liu. 使用胞嘧啶和腺嘌呤碱基编辑器在哺乳动物细胞中进行精确基因组编辑。《Nature
    Protocols》，16(2):1089–1128, 2021。'
- en: '[27] Gue-Ho Hwang, You Kyeong Jeong, Omer Habib, Sung-Ah Hong, Kayeong Lim,
    Jin-Soo Kim, and Sangsu Bae. Pe-designer and pe-analyzer: web-based design and
    analysis tools for crispr prime editing. Nucleic Acids Research, 49(W1):W499–W504,
    2021.'
  id: totrans-190
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[27] Gue-Ho Hwang, You Kyeong Jeong, Omer Habib, Sung-Ah Hong, Kayeong Lim,
    Jin-Soo Kim 和 Sangsu Bae. Pe-designer 和 Pe-analyzer：用于CRISPR Prime编辑的基于网络的设计和分析工具。《Nucleic
    Acids Research》，49(W1):W499–W504, 2021。'
- en: '[28] Hui Kwon Kim, Seonwoo Min, Myungjae Song, Soobin Jung, Jae Woo Choi, Younggwang
    Kim, Sangeun Lee, Sungroh Yoon, and Hyongbum Kim. Deep learning improves prediction
    of crispr–cpf1 guide rna activity. Nature biotechnology, 36(3):239–241, 2018.'
  id: totrans-191
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[28] Hui Kwon Kim, Seonwoo Min, Myungjae Song, Soobin Jung, Jae Woo Choi, Younggwang
    Kim, Sangeun Lee, Sungroh Yoon 和 Hyongbum Kim. 深度学习提高了CRISPR-Cpf1引导RNA活性的预测。《Nature
    Biotechnology》，36(3):239–241, 2018。'
- en: '[29] Silvana Konermann, Mark D Brigham, Alexandro E Trevino, Patrick D Hsu,
    Matthias Heidenreich, Le Cong, Randall J Platt, David A Scott, George M Church,
    and Feng Zhang. Optical control of mammalian endogenous transcription and epigenetic
    states. Nature, 500(7463):472–476, 2013.'
  id: totrans-192
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[29] Silvana Konermann, Mark D Brigham, Alexandro E Trevino, Patrick D Hsu,
    Matthias Heidenreich, Le Cong, Randall J Platt, David A Scott, George M Church
    和 Feng Zhang. 对哺乳动物内源性转录和表观遗传状态的光学控制。《Nature》，500(7463):472–476, 2013。'
- en: '[30] Eric S Lander, Françoise Baylis, Feng Zhang, Emmanuelle Charpentier, Paul
    Berg, Catherine Bourgain, Bärbel Friedrich, J Keith Joung, Jinsong Li, David Liu,
    et al. Adopt a moratorium on heritable genome editing. Nature, 567(7747):165–168,
    2019.'
  id: totrans-193
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[30] Eric S Lander, Françoise Baylis, Feng Zhang, Emmanuelle Charpentier, Paul
    Berg, Catherine Bourgain, Bärbel Friedrich, J Keith Joung, Jinsong Li, David Liu
    等. 采用关于遗传基因组编辑的暂停建议。《Nature》，567(7747):165–168, 2019。'
- en: '[31] Tianhao Li, Sandesh Shetty, Advaith Kamath, Ajay Jaiswal, Xiaoqian Jiang,
    Ying Ding, and Yejin Kim. Cancergpt for few shot drug pair synergy prediction
    using large pretrained language models. npj Digital Medicine, 7(1):40, 2024.'
  id: totrans-194
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[31] Tianhao Li, Sandesh Shetty, Advaith Kamath, Ajay Jaiswal, Xiaoqian Jiang,
    Ying Ding 和 Yejin Kim. Cancergpt 用于通过大型预训练语言模型进行少量样本药物配对协同预测。npj 数字医学, 7(1):40,
    2024。'
- en: '[32] Ruibo Liu, Jason Wei, Shixiang Shane Gu, Te-Yen Wu, Soroush Vosoughi,
    Claire Cui, Denny Zhou, and Andrew M Dai. Mind’s eye: Grounded language model
    reasoning through simulation. arXiv preprint arXiv:2210.05359, 2022.'
  id: totrans-195
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[32] Ruibo Liu, Jason Wei, Shixiang Shane Gu, Te-Yen Wu, Soroush Vosoughi,
    Claire Cui, Denny Zhou 和 Andrew M Dai. 心灵之眼：通过模拟实现的有根语言模型推理。arXiv 预印本 arXiv:2210.05359,
    2022。'
- en: '[33] Morgan L Maeder, Samantha J Linder, Vincent M Cascio, Yanfang Fu, Quan H
    Ho, and J Keith Joung. Crispr rna–guided activation of endogenous human genes.
    Nature methods, 10(10):977–979, 2013.'
  id: totrans-196
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[33] Morgan L Maeder, Samantha J Linder, Vincent M Cascio, Yanfang Fu, Quan
    H Ho 和 J Keith Joung. Crispr RNA–引导的内源性人类基因激活。自然方法, 10(10):977–979, 2013。'
- en: '[34] Prashant Mali, Kevin M Esvelt, and George M Church. Cas9 as a versatile
    tool for engineering biology. Nature methods, 10(10):957–963, 2013.'
  id: totrans-197
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[34] Prashant Mali, Kevin M Esvelt 和 George M Church. Cas9 作为工程生物学的多功能工具。自然方法,
    10(10):957–963, 2013。'
- en: '[35] Abby V McGee, Yanjing V Liu, Audrey L Griffith, Zsofia M Szegletes, Bronte
    Wen, Carolyn Kraus, Nathan W Miller, Ryan J Steger, Berta Escude Velasco, Justin A
    Bosch, et al. Modular vector assembly enables rapid assessment of emerging crispr
    technologies. Cell Genomics, 4(3), 2024.'
  id: totrans-198
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[35] Abby V McGee, Yanjing V Liu, Audrey L Griffith, Zsofia M Szegletes, Bronte
    Wen, Carolyn Kraus, Nathan W Miller, Ryan J Steger, Berta Escude Velasco, Justin
    A Bosch 等. 模块化载体组装实现了对新兴 crispr 技术的快速评估。细胞基因组学, 4(3), 2024。'
- en: '[36] John A Morris, Jahan A Rahman, Xinyi Guo, and Neville E Sanjana. Automated
    design of crispr prime editors for 56,000 human pathogenic variants. Iscience,
    24(11), 2021.'
  id: totrans-199
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[36] John A Morris, Jahan A Rahman, Xinyi Guo 和 Neville E Sanjana. 自动化设计 56,000
    种人类致病变异体的 crispr prime 编辑器。Iscience, 24(11), 2021。'
- en: '[37] Shishir G Patil, Tianjun Zhang, Xin Wang, and Joseph E Gonzalez. Gorilla:
    Large language model connected with massive apis. arXiv preprint arXiv:2305.15334,
    2023.'
  id: totrans-200
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[37] Shishir G Patil, Tianjun Zhang, Xin Wang 和 Joseph E Gonzalez. Gorilla：与大量
    API 连接的大型语言模型。arXiv 预印本 arXiv:2305.15334, 2023。'
- en: '[38] Pablo Perez-Pinera, D Dewran Kocak, Christopher M Vockley, Andrew F Adler,
    Ami M Kabadi, Lauren R Polstein, Pratiksha I Thakore, Katherine A Glass, David G
    Ousterout, Kam W Leong, et al. Rna-guided gene activation by crispr-cas9–based
    transcription factors. Nature methods, 10(10):973–976, 2013.'
  id: totrans-201
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[38] Pablo Perez-Pinera, D Dewran Kocak, Christopher M Vockley, Andrew F Adler,
    Ami M Kabadi, Lauren R Polstein, Pratiksha I Thakore, Katherine A Glass, David
    G Ousterout, Kam W Leong 等. 基于 crispr-cas9 的转录因子的 RNA 引导基因激活。自然方法, 10(10):973–976,
    2013。'
- en: '[39] Adrian Pickar-Oliver and Charles A Gersbach. The next generation of crispr–cas
    technologies and applications. Nature reviews Molecular cell biology, 20(8):490–507,
    2019.'
  id: totrans-202
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[39] Adrian Pickar-Oliver 和 Charles A Gersbach. 下一代 crispr–cas 技术和应用。自然评论 分子细胞生物学,
    20(8):490–507, 2019。'
- en: '[40] Lei S Qi, Matthew H Larson, Luke A Gilbert, Jennifer A Doudna, Jonathan S
    Weissman, Adam P Arkin, and Wendell A Lim. Repurposing crispr as an rna-guided
    platform for sequence-specific control of gene expression. Cell, 152(5):1173–1183,
    2013.'
  id: totrans-203
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[40] Lei S Qi, Matthew H Larson, Luke A Gilbert, Jennifer A Doudna, Jonathan
    S Weissman, Adam P Arkin 和 Wendell A Lim. 重新利用 crispr 作为 RNA 引导的平台进行序列特异性基因表达控制。细胞,
    152(5):1173–1183, 2013。'
- en: '[41] FAFA Ran, Patrick D Hsu, Jason Wright, Vineeta Agarwala, David A Scott,
    and Feng Zhang. Genome engineering using the crispr-cas9 system. Nature protocols,
    8(11):2281–2308, 2013.'
  id: totrans-204
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[41] FAFA Ran, Patrick D Hsu, Jason Wright, Vineeta Agarwala, David A Scott
    和 Feng Zhang. 使用 crispr-cas9 系统进行基因组工程。自然协议, 8(11):2281–2308, 2013。'
- en: '[42] Jeffry D Sander and J Keith Joung. Crispr-cas systems for editing, regulating
    and targeting genomes. Nature biotechnology, 32(4):347–355, 2014.'
  id: totrans-205
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[42] Jeffry D Sander 和 J Keith Joung. 用于编辑、调控和靶向基因组的 crispr-cas 系统。自然生物技术,
    32(4):347–355, 2014。'
- en: '[43] Kendall R Sanson, Ruth E Hanna, Mudra Hegde, Katherine F Donovan, Christine
    Strand, Meagan E Sullender, Emma W Vaimberg, Amy Goodale, David E Root, Federica
    Piccioni, et al. Optimized libraries for crispr-cas9 genetic screens with multiple
    modalities. Nature communications, 9(1):5416, 2018.'
  id: totrans-206
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[43] Kendall R Sanson, Ruth E Hanna, Mudra Hegde, Katherine F Donovan, Christine
    Strand, Meagan E Sullender, Emma W Vaimberg, Amy Goodale, David E Root, Federica
    Piccioni 等. 优化的 crispr-cas9 遗传筛选库，具有多种模式。自然通讯, 9(1):5416, 2018。'
- en: '[44] Timo Schick, Jane Dwivedi-Yu, Roberto Dessì, Roberta Raileanu, Maria Lomeli,
    Eric Hambro, Luke Zettlemoyer, Nicola Cancedda, and Thomas Scialom. Toolformer:
    Language models can teach themselves to use tools. Advances in Neural Information
    Processing Systems, 36, 2024.'
  id: totrans-207
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[44] Timo Schick, Jane Dwivedi-Yu, Roberto Dessì, Roberta Raileanu, Maria Lomeli,
    Eric Hambro, Luke Zettlemoyer, Nicola Cancedda, 和 Thomas Scialom. Toolformer:
    语言模型可以自我学习使用工具。神经信息处理系统进展, 36, 2024.'
- en: '[45] Ophir Shalem, Neville E Sanjana, and Feng Zhang. High-throughput functional
    genomics using crispr–cas9. Nature Reviews Genetics, 16(5):299–311, 2015.'
  id: totrans-208
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[45] Ophir Shalem, Neville E Sanjana, 和 Feng Zhang. 使用 CRISPR-Cas9 进行高通量功能基因组学。自然评论遗传学,
    16(5):299–311, 2015.'
- en: '[46] Yongliang Shen, Kaitao Song, Xu Tan, Dongsheng Li, Weiming Lu, and Yueting
    Zhuang. Hugginggpt: Solving ai tasks with chatgpt and its friends in hugging face.
    Advances in Neural Information Processing Systems, 36, 2024.'
  id: totrans-209
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[46] Yongliang Shen, Kaitao Song, Xu Tan, Dongsheng Li, Weiming Lu, 和 Yueting
    Zhuang. Hugginggpt: 使用 ChatGPT 及其在 Hugging Face 上的朋友解决 AI 任务。神经信息处理系统进展, 36, 2024.'
- en: '[47] Gemini Team, Rohan Anil, Sebastian Borgeaud, Yonghui Wu, Jean-Baptiste
    Alayrac, Jiahui Yu, Radu Soricut, Johan Schalkwyk, Andrew M Dai, Anja Hauth, et al.
    Gemini: a family of highly capable multimodal models. arXiv preprint arXiv:2312.11805,
    2023.'
  id: totrans-210
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[47] Gemini Team, Rohan Anil, Sebastian Borgeaud, Yonghui Wu, Jean-Baptiste
    Alayrac, Jiahui Yu, Radu Soricut, Johan Schalkwyk, Andrew M Dai, Anja Hauth 等.
    Gemini: 一系列高能力的多模态模型。arXiv 预印本 arXiv:2312.11805, 2023.'
- en: '[48] Andreas Untergasser, Ioana Cutcutache, Triinu Koressaar, Jian Ye, Brant C
    Faircloth, Maido Remm, and Steven G Rozen. Primer3—new capabilities and interfaces.
    Nucleic acids research, 40(15):e115–e115, 2012.'
  id: totrans-211
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[48] Andreas Untergasser, Ioana Cutcutache, Triinu Koressaar, Jian Ye, Brant
    C Faircloth, Maido Remm, 和 Steven G Rozen. Primer3——新功能和接口。核酸研究, 40(15):e115–e115,
    2012.'
- en: '[49] Guanzhi Wang, Yuqi Xie, Yunfan Jiang, Ajay Mandlekar, Chaowei Xiao, Yuke
    Zhu, Linxi Fan, and Anima Anandkumar. Voyager: An open-ended embodied agent with
    large language models. arXiv preprint arXiv:2305.16291, 2023.'
  id: totrans-212
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[49] Guanzhi Wang, Yuqi Xie, Yunfan Jiang, Ajay Mandlekar, Chaowei Xiao, Yuke
    Zhu, Linxi Fan, 和 Anima Anandkumar. Voyager: 一个开放式的具身代理与大型语言模型。arXiv 预印本 arXiv:2305.16291,
    2023.'
- en: '[50] Jason Wei, Xuezhi Wang, Dale Schuurmans, Maarten Bosma, Fei Xia, Ed Chi,
    Quoc V Le, Denny Zhou, et al. Chain-of-thought prompting elicits reasoning in
    large language models. Advances in neural information processing systems, 35:24824–24837,
    2022.'
  id: totrans-213
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[50] Jason Wei, Xuezhi Wang, Dale Schuurmans, Maarten Bosma, Fei Xia, Ed Chi,
    Quoc V Le, Denny Zhou 等. Chain-of-thought 提示激发大型语言模型中的推理。神经信息处理系统进展, 35:24824–24837,
    2022.'
- en: '[51] Shijie Wu, Ozan Irsoy, Steven Lu, Vadim Dabravolski, Mark Dredze, Sebastian
    Gehrmann, Prabhanjan Kambadur, David Rosenberg, and Gideon Mann. Bloomberggpt:
    A large language model for finance. arXiv preprint arXiv:2303.17564, 2023.'
  id: totrans-214
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[51] Shijie Wu, Ozan Irsoy, Steven Lu, Vadim Dabravolski, Mark Dredze, Sebastian
    Gehrmann, Prabhanjan Kambadur, David Rosenberg, 和 Gideon Mann. Bloomberggpt: 一种金融领域的大型语言模型。arXiv
    预印本 arXiv:2303.17564, 2023.'
- en: '[52] Chengrun Yang, Xuezhi Wang, Yifeng Lu, Hanxiao Liu, Quoc V Le, Denny Zhou,
    and Xinyun Chen. Large language models as optimizers. arXiv preprint arXiv:2309.03409,
    2023.'
  id: totrans-215
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[52] Chengrun Yang, Xuezhi Wang, Yifeng Lu, Hanxiao Liu, Quoc V Le, Denny Zhou,
    和 Xinyun Chen. 大型语言模型作为优化器。arXiv 预印本 arXiv:2309.03409, 2023.'
- en: '[53] Shunyu Yao, Jeffrey Zhao, Dian Yu, Nan Du, Izhak Shafran, Karthik Narasimhan,
    and Yuan Cao. React: Synergizing reasoning and acting in language models. arXiv
    preprint arXiv:2210.03629, 2022.'
  id: totrans-216
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[53] Shunyu Yao, Jeffrey Zhao, Dian Yu, Nan Du, Izhak Shafran, Karthik Narasimhan,
    和 Yuan Cao. React: 在语言模型中协同推理和行动。arXiv 预印本 arXiv:2210.03629, 2022.'
- en: '[54] Denny Zhou, Nathanael Schärli, Le Hou, Jason Wei, Nathan Scales, Xuezhi
    Wang, Dale Schuurmans, Claire Cui, Olivier Bousquet, Quoc Le, et al. Least-to-most
    prompting enables complex reasoning in large language models. arXiv preprint arXiv:2205.10625,
    2022.'
  id: totrans-217
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: '[54] Denny Zhou, Nathanael Schärli, Le Hou, Jason Wei, Nathan Scales, Xuezhi
    Wang, Dale Schuurmans, Claire Cui, Olivier Bousquet, Quoc Le 等. 从少到多的提示使大型语言模型能够进行复杂推理。arXiv
    预印本 arXiv:2205.10625, 2022.'
- en: Appendix A Failure Cases of GPT-4
  id: totrans-218
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 附录 A GPT-4 的失败案例
- en: The GPT version we use is gpt-4-0613.
  id: totrans-219
  prefs: []
  type: TYPE_NORMAL
  zh: 我们使用的 GPT 版本是 gpt-4-0613。
- en: A.1 Examples of inaccurate information
  id: totrans-220
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: A.1 不准确的信息示例
- en: 'Example 1:'
  id: totrans-221
  prefs:
  - PREF_H4
  type: TYPE_NORMAL
  zh: '示例 1:'
- en: 'Prompt: Which specific base editing system I should use to broadly introduce
    mutations to human EGFR gene?'
  id: totrans-222
  prefs: []
  type: TYPE_NORMAL
  zh: 提示：我应该使用哪种特定的碱基编辑系统来广泛引入人类 EGFR 基因的突变？
- en: 'GPT4: If you are looking to induce a spectrum of mutations in the human EGFR
    gene to study the phenotypic implications of these mutations, utilizing multiple
    base editing systems would be beneficial. 1\. **Adenine Base Editors (ABEs):**
    These can be used to induce A-G transitions in your target gene. ABEs are helpful
    as they induce minimal bystander mutations and indels compared to cytosine base
    editors (CBEs). 2\. **Cytosine Base Editors (CBEs):** You can incorporate these
    when a C to T change (or G to A on the opposite strand) is desired in your target
    gene. Examples of CBEs include BE3, Target-AID, and BE4. 3\. **Prime Editing:**
    If more diverse mutations beyond simple transitions are needed, or insertion/deletion
    mutations are needed, consider using prime editing. Although more complex, the
    versatility of prime editing allows it to create a wider range of mutations without
    inducing double-strand breaks or relying on homology-directed repair. To ensure
    that your mutations are broad, careful design of guide RNAs for each specific
    location of your target gene where mutations are required is necessary. These
    gRNAs should be specific to the location in the target gene where A-G or C-T substitutions
    are desired. However, take note that introducing broad mutations could also increase
    the possibility of off-target effects, hence it is crucial to have stringent control
    of your editing experiment, and thorough validation of the induced mutations by
    techniques such as Sanger sequencing or Next-Generation Sequencing (NGS). As always,
    bear in mind the ethical considerations and regulations applicable to your region,
    as well as potential biosafety issues, especially when working with oncogenes
    such as EGFR.'
  id: totrans-223
  prefs: []
  type: TYPE_NORMAL
  zh: 'GPT4: 如果你希望诱导人类EGFR基因的突变谱，以研究这些突变的表型影响，使用多种**碱基编辑系统**将会是有益的。1. **腺苷酸碱基编辑器 (ABEs)**:
    这些可以用于在你的目标基因中诱导A-G转换。与**胞嘧啶碱基编辑器 (CBEs)**相比，ABEs有助于减少旁观者突变和插入/缺失突变。2. **胞嘧啶碱基编辑器
    (CBEs)**: 当你的目标基因中需要C到T变化（或在对链上G到A变化）时，可以使用这些。CBEs的例子包括BE3、Target-AID和BE4。3. **原位编辑**:
    如果需要比简单转换更广泛的突变，或者需要插入/缺失突变，可以考虑使用原位编辑。尽管更复杂，但原位编辑的多样性使其能够创建更广泛的突变，而无需诱导双链断裂或依赖同源重组修复。为了确保你的突变广泛，需要仔细设计每个目标基因中需要突变的具体位置的引导RNA。这些gRNA应针对目标基因中A-G或C-T替换所需的位置。然而，注意引入广泛的突变可能也会增加非特异性效果的可能性，因此严格控制你的编辑实验，并通过如Sanger测序或下一代测序（NGS）等技术进行彻底验证是至关重要的。始终牢记适用于你所在地区的伦理考虑和法规，以及潜在的生物安全问题，特别是在处理如EGFR这样的癌基因时。'
- en: 'Note: The answer fails to mention the specific expanded-window/non-specific
    base editors. It provides irrelevant information on ABE, CBE and prime editing.'
  id: totrans-224
  prefs: []
  type: TYPE_NORMAL
  zh: 'Note: 回答未提及特定的扩展窗口/非特异性碱基编辑器。提供了不相关的信息关于ABE、CBE和原位编辑。'
- en: 'Example 2:'
  id: totrans-225
  prefs:
  - PREF_H4
  type: TYPE_NORMAL
  zh: 'Example 2:'
- en: 'Prompt: Which one of the delivery method I should use to deliver CRISPR knockout
    systems in HepG2 cell line?'
  id: totrans-226
  prefs: []
  type: TYPE_NORMAL
  zh: 'Prompt: 我应该使用哪种传递方法将CRISPR敲除系统传递到HepG2细胞系中？'
- en: 'GPT4: Lipofection is commonly used to deliver CRISPR knockout systems into
    HepG2 cells. Lipofectamine 3000 is a reagent often utilized for this purpose.
    Remember to take into account that the transfection conditions might need to be
    optimized based on the specific characteristics of your experimental design. Always
    follow the manufacturer’s guidelines related to the specific CRISPR system being
    used in order to ensure the highest level of efficiency. If for any reason lipofection
    is not the preferable choice, electroporation or lentiviral transduction could
    be other options depending on the specifics of the experiment and resources available.'
  id: totrans-227
  prefs: []
  type: TYPE_NORMAL
  zh: 'GPT4: **脂质体转染**通常用于将CRISPR敲除系统传递到HepG2细胞中。**Lipofectamine 3000**是常用于此目的的试剂。请记住，转染条件可能需要根据实验设计的具体特征进行优化。始终遵循与所使用的特定CRISPR系统相关的制造商指南，以确保最高效率。如果由于某些原因脂质体转染不是首选，可以考虑电穿孔或慢病毒转导，这取决于实验的具体情况和可用资源。'
- en: 'Note: As HepG2 is a well-known hard-to-transfect cell line, GPT4 provides inaccurate
    information of using lipofection to deliver the CRISPR knockout system as the
    top choice.'
  id: totrans-228
  prefs: []
  type: TYPE_NORMAL
  zh: 'Note: 由于HepG2是一种著名的难转染细胞系，GPT4提供了不准确的使用脂质体转染作为首选的建议。'
- en: 'Example 3:'
  id: totrans-229
  prefs:
  - PREF_H4
  type: TYPE_NORMAL
  zh: 'Example 3:'
- en: 'Prompt: How should I verify the CRISPR knockout of EGFR in the A549 cell line?'
  id: totrans-230
  prefs: []
  type: TYPE_NORMAL
  zh: 'Prompt: 我应该如何验证A549细胞系中的EGFR CRISPR敲除？'
- en: 'GPT4: After performing a CRISPR-Cas9 mediated knockout of EGFR in A549 cells,
    you should confirm the knockout on a genotypic and phenotypic level. Below are
    some methods for assessing this: 1\. PCR and Sequencing: Extract genomic DNA from
    the transfected cells and conduct PCR to amplify the region surrounding the CRISPR
    target site. Subsequent Sanger sequencing can identify any insertions or deletions
    (indels) at the target site. 2\. T7 Endonuclease I Assay or Surveyor Nuclease
    Assay: These mismatch cleavage assays can also be used to detect the indels introduced
    by CRISPR-Cas9 activity. 3\. Western Blot: To confirm loss of EGFR expression
    at the protein level, perform a Western blot using an anti-EGFR antibody. You
    should observe a lack of or significant reduction in the EGFR band in the CRISPR-treated
    cells compared to controls. 4\. Immunofluorescence: Perform immunofluorescence
    staining for EGFR. The CRISPR-treated A549 cells should show lower fluorescence
    signal compared to control cells. 5\. Cell Function Analysis: As the knockout
    of EGFR can impact EGFR downstream signaling and cell proliferation, the analysis
    of cell growth, migration, or signaling changes can provide further evidence of
    functional knockout. 6\. qRT-PCR: To assess EGFR mRNA expression levels, quantitative
    real-time PCR can be performed. 7\. Next-Generation Sequencing (NGS): For a more
    detailed understanding of the specific mutations and possible off-target effects
    introduced by CRISPR, NGS can be performed. Always include appropriate controls
    in your experiment and conduct the experiments in triplicates for statistical
    significance. It is generally recommended to use multiple verification methods
    to validate the results.'
  id: totrans-231
  prefs: []
  type: TYPE_NORMAL
  zh: GPT4：在 A549 细胞中进行 CRISPR-Cas9 介导的 EGFR 敲除后，您应在基因型和表型层面确认敲除效果。以下是一些评估方法：1. PCR
    和测序：从转染细胞中提取基因组 DNA，并进行 PCR 扩增 CRISPR 目标位点周围的区域。随后的 Sanger 测序可以识别目标位点的插入或缺失（indels）。2.
    T7 内切酶 I 检测或 Surveyor 核酸酶检测：这些错配切割检测也可用于检测 CRISPR-Cas9 活动引入的 indels。3. Western
    Blot：为了确认 EGFR 在蛋白质水平的缺失，使用抗 EGFR 抗体进行 Western blot。与对照组相比，您应该观察到 CRISPR 处理的细胞中
    EGFR 带的缺失或显著减少。4. 免疫荧光：进行 EGFR 的免疫荧光染色。与对照细胞相比，CRISPR 处理的 A549 细胞应显示出较低的荧光信号。5.
    细胞功能分析：由于 EGFR 的敲除可能影响 EGFR 下游信号传导和细胞增殖，细胞生长、迁移或信号变化的分析可以提供功能性敲除的进一步证据。6. qRT-PCR：为了评估
    EGFR mRNA 表达水平，可以进行定量实时 PCR。7. 高通量测序（NGS）：为了更详细地了解 CRISPR 引入的特定突变和可能的脱靶效应，可以进行
    NGS。在实验中始终包括适当的对照，并进行三次重复实验以确保统计学意义。通常建议使用多种验证方法来验证结果。
- en: 'Note: The answer provides wrong information of using qRT-PCR to validate the
    knockout status. It is known that qRT-PCR is not a reliable technique to assess
    gene knockout edits generated with a single guide RNA.'
  id: totrans-232
  prefs: []
  type: TYPE_NORMAL
  zh: 注意：答案提供了错误的信息，即使用 qRT-PCR 来验证敲除状态。已知 qRT-PCR 不是评估使用单导 RNA 生成的基因敲除编辑的可靠技术。
- en: 'Example 4:'
  id: totrans-233
  prefs:
  - PREF_H4
  type: TYPE_NORMAL
  zh: 示例 4：
- en: 'Prompt: Could you give me a set of sgRNA sequences of Cas9 targeting human
    EGFR?'
  id: totrans-234
  prefs: []
  type: TYPE_NORMAL
  zh: 提示：您能提供一组针对人类 EGFR 的 Cas9 sgRNA 序列吗？
- en: 'GPT4: It’s important to note that the efficiency and specificity of sgRNA sequences
    can depend on several factors, including the particular experimental conditions
    and target population of cells. Here are a few sgRNA sequences targeting human
    EGFR that have been used in published studies: 1\. 5’- GTGGAGTGTGTTGAGCTTGG -3’
    2\. 5’- GCGTGCAGATGAACTTCTCAAGG -3’ 3\. 5’- GCTGGTCCTGGAGGAGGTCAAGG -3’ 4\. 5’-
    CCTGGAGGAGGTCAGTGTGTAGG -3’ 5\. 5’- GTGTGTTGAGCTTGGAGTTCGGG -3’ These sequences
    target different exons within human EGFR. Note that your selection from these
    sequences should be driven by desired outcomes. Some may need considerations such
    as possible pre-existing single nucleotide polymorphisms, the uniqueness of the
    sequence for the genome, and the efficiency of the particular sgRNA. Please also
    remember that it will be essential to validate the on-target and off-target effects
    of your selected sgRNA in your specific experimental context. Additional steps
    may include sequencing and functional assays to confirm successful knockout. There
    are online tools available such as Benchling, CHOPCHOP, and CRISPOR, which can
    assist you in designing sgRNA sequences for your specific needs.'
  id: totrans-235
  prefs: []
  type: TYPE_NORMAL
  zh: GPT4：重要的是要注意，sgRNA 序列的效率和特异性可能取决于多个因素，包括特定的实验条件和靶细胞群体。以下是一些针对人类 EGFR 的 sgRNA
    序列，这些序列已在已发表的研究中使用过：1\. 5’- GTGGAGTGTGTTGAGCTTGG -3’ 2\. 5’- GCGTGCAGATGAACTTCTCAAGG
    -3’ 3\. 5’- GCTGGTCCTGGAGGAGGTCAAGG -3’ 4\. 5’- CCTGGAGGAGGTCAGTGTGTAGG -3’ 5\.
    5’- GTGTGTTGAGCTTGGAGTTCGGG -3’ 这些序列针对人类 EGFR 的不同外显子。注意，你从这些序列中选择的序列应基于期望的结果。一些可能需要考虑的因素包括可能的先天性单核苷酸多态性、序列对基因组的独特性以及特定
    sgRNA 的效率。请记住，在特定实验环境中验证所选 sgRNA 的靶向效果和非靶向效果是至关重要的。附加步骤可能包括测序和功能测定，以确认成功的基因敲除。在线工具如
    Benchling、CHOPCHOP 和 CRISPOR 可以帮助你设计适合你需求的 sgRNA 序列。
- en: 'Note: The sequences provided by GPT4 did not align to the sequence of human
    EGFR sequences.'
  id: totrans-236
  prefs: []
  type: TYPE_NORMAL
  zh: 注意：GPT4 提供的序列与人类 EGFR 序列不匹配。
- en: 'Example 5:'
  id: totrans-237
  prefs:
  - PREF_H4
  type: TYPE_NORMAL
  zh: 示例 5：
- en: 'Prompt: Could you give me the sgRNA sequence for CRISPR activation of human
    TGFBR1'
  id: totrans-238
  prefs: []
  type: TYPE_NORMAL
  zh: 提示：你能提供用于激活人类 TGFBR1 的 sgRNA 序列吗？
- en: 'GPT4: To use CRISPRa (CRISPR activation) for gene activation, a series of sgRNAs
    that target various regions near the transcription start site of the gene of interest
    are typically used. Below is a set of TGFBR1 targeting sgRNA sequences found in
    the literature. These sgRNA sequences target the promoter of TGFBR1:'
  id: totrans-239
  prefs: []
  type: TYPE_NORMAL
  zh: GPT4：要使用 CRISPRa（CRISPR 激活）进行基因激活，通常使用一系列 sgRNA，这些 sgRNA 靶向感兴趣基因的转录起始位点附近的不同区域。以下是文献中找到的针对
    TGFBR1 的 sgRNA 序列。这些 sgRNA 序列靶向 TGFBR1 的启动子：
- en: 1\. 5’- GAGTTAGGTTTCCCGTTGCG -3’ 2\. 5’- CAGGGTGGTGAGGCCATCTA -3’ 3\. 5’- GCCATCTAGTTCTCTCCGGA
    -3’ 4\. 5’- CAGACGTTGGAGGAGTTAGG -3’ 5\. 5’- TGACCACGGTCGCGCTCTCC -3’
  id: totrans-240
  prefs: []
  type: TYPE_NORMAL
  zh: 1\. 5’- GAGTTAGGTTTCCCGTTGCG -3’ 2\. 5’- CAGGGTGGTGAGGCCATCTA -3’ 3\. 5’- GCCATCTAGTTCTCTCCGGA
    -3’ 4\. 5’- CAGACGTTGGAGGAGTTAGG -3’ 5\. 5’- TGACCACGGTCGCGCTCTCC -3’
- en: In designing and choosing the most appropriate sgRNA, the use of software and
    online prediction tools, such as Benchling, Optimized CRISPR Design, and CHOPCHOP,
    can be highly beneficial. Importantly, after performing CRISPRa, it’s crucial
    to verify upregulation of TGFBR1 at both RNA (qRT-PCR) and protein (Western blot
    or ELISA) levels, and also monitor any change in cell phenotype. Off-target effects
    should also be evaluated. As with any experimental procedure, several control
    experiments, including a non-targeting sgRNA control, should be included.
  id: totrans-241
  prefs: []
  type: TYPE_NORMAL
  zh: 在设计和选择最合适的 sgRNA 时，使用软件和在线预测工具，如 Benchling、Optimized CRISPR Design 和 CHOPCHOP，可以非常有帮助。重要的是，在进行
    CRISPRa 后，必须在 RNA (qRT-PCR) 和蛋白质 (Western blot 或 ELISA) 水平验证 TGFBR1 的上调情况，并监测任何细胞表型的变化。还应评估非靶向效应。与任何实验程序一样，应包括多个对照实验，包括一个非靶向
    sgRNA 对照。
- en: 'Note: The sequences provided by GPT4 did not align to the sequence of human
    TGFBR1 sequences.'
  id: totrans-242
  prefs: []
  type: TYPE_NORMAL
  zh: 注意：GPT4 提供的序列与人类 TGFBR1 序列不匹配。
- en: 'Example 6:'
  id: totrans-243
  prefs:
  - PREF_H4
  type: TYPE_NORMAL
  zh: 示例 6：
- en: 'Prompt: Could you give me sequences of PCR primers to verify knockout of human
    EGFR using this guide ATACACCGTGCCGAACGCAC ?'
  id: totrans-244
  prefs: []
  type: TYPE_NORMAL
  zh: 提示：你能提供用于验证人类 EGFR 基因敲除的 PCR 引物序列吗？使用此指南 ATACACCGTGCCGAACGCAC？
- en: 'GPT4: To design PCR primers for verifying a knockout, you typically need to
    know the genomic context around your cut site which is located in the EGFR gene.
    The given gRNA sequence (ATACACCGTGCCGAACGCAC) targets human EGFR gene at the
    site 55,244,314 - 55,244,333 on chromosome 7 according to the Genome Reference
    Consortium Human Build 38 patch release 13 (GRCh38.p13). Based on this position,
    I suggest to use following primer sequences: Forward primer: CAGGAAGGAAGGAGGAGGAAG
    Reverse primer: GCAGCACGAGCTTAGTTAGG These primers are designed for approximately
    200 bp amplicon size and expected to perform reasonably well under standard PCR
    conditions. For best results, adjust conditions based on your specific PCR reagents.
    The resulting PCR products should then be analyzed using methods such as Sanger
    sequencing or Next generation sequencing (NGS) to verify mutations indicative
    of knockout. However, please note that any online provided sequences should be
    further verified. If possible, consult with a geneticist/biologist/professional
    tool before utilization.'
  id: totrans-245
  prefs: []
  type: TYPE_NORMAL
  zh: GPT4：为了设计用于验证基因敲除的 PCR 引物，你通常需要了解你的切割位点周围的基因组背景，而这个切割位点位于 EGFR 基因中。根据基因组参考联盟人类版本
    38 补丁版本 13（GRCh38.p13），给定的 gRNA 序列（ATACACCGTGCCGAACGCAC）靶向人类 EGFR 基因位于第 7 号染色体的
    55,244,314 - 55,244,333 位点。根据这个位置，我建议使用以下引物序列：正向引物：CAGGAAGGAAGGAGGAGGAAG 反向引物：GCAGCACGAGCTTAGTTAGG
    这些引物设计用于大约 200 bp 的扩增子大小，并且预计在标准 PCR 条件下表现良好。为了获得最佳结果，请根据你特定的 PCR 试剂调整条件。所得的 PCR
    产品应使用如 Sanger 测序或下一代测序（NGS）等方法进行分析，以验证指示敲除的突变。然而，请注意，任何在线提供的序列应进一步验证。如果可能的话，在使用之前请咨询遗传学家/生物学家/专业工具。
- en: 'Note: The primer sequences provided by GPT4 did not align to the sequence of
    human TGFBR1 sequences.'
  id: totrans-246
  prefs: []
  type: TYPE_NORMAL
  zh: 注意：GPT4 提供的引物序列与人类 TGFBR1 序列不匹配。
- en: 'A.2 Examples of incomplete information:'
  id: totrans-247
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: A.2 不完整信息的示例：
- en: 'Example 1:'
  id: totrans-248
  prefs:
  - PREF_H4
  type: TYPE_NORMAL
  zh: 示例 1：
- en: 'Prompt: How should I knock out human EGFR in my A549 cell line?'
  id: totrans-249
  prefs: []
  type: TYPE_NORMAL
  zh: 提示：我应该如何在我的 A549 细胞系中敲除人类 EGFR？
- en: 'GPT4: Here are the general steps to knockout the human EGFR gene in A549 cells
    using the CRISPR-Cas9 system:'
  id: totrans-250
  prefs: []
  type: TYPE_NORMAL
  zh: GPT4：以下是使用 CRISPR-Cas9 系统在 A549 细胞中敲除人类 EGFR 基因的一般步骤：
- en: '1\. gRNA Design: First, you have to design guide RNAs (gRNAs) that target the
    EGFR gene. There are many online tools available to assist you in designing gRNAs
    with high specificity and efficiency, like the CRISPOR and the Benchling tools.
    2\. Cloning: Clone the gRNAs into a plasmid that also expresses the Cas9 nuclease.
    This plasmid can either express the gRNA and Cas9 from separate promoters or express
    a single transcript that includes both the gRNA and Cas9 sequences. 2\. Transfection:
    Deliver the plasmid containing the gRNA and Cas9 into the A549 cells. This can
    be achieved using a lipofection reagent such as Lipofectamine 3000, following
    the manufacturer’s instructions. 3\. Verification: After allowing time for the
    CRISPR-Cas9 system to induce double-strand breaks and errors in the DNA repair,
    which will result in insertions or deletions (indels) disrupting the EGFR gene,
    you have to verify the knockout. Genomic DNA PCR with subsequent Sanger sequencing
    or a mismatch detection assay like T7 endonuclease I or Surveyor nuclease can
    be used to confirm indels at the target site. 4\. Functional Assays: This step
    involves verification of the knockout at the protein level. Western blotting or
    immunostaining against EGFR can be used to confirm reduced or absent protein level.
    Additionally, you may wish to determine the effects of the knockout on cell function,
    which might include effects on EGFR downstream signaling and cellular processes
    like proliferation and migration. 5\. Validation: Validate the results using multiple
    clones and repeat the experiments to ensure the observed results are consistent
    and reproducible. Note: It is very important to always include appropriate controls,
    such as untransfected cells or cells transfected with a non-targeting gRNA, in
    your experiments. Remember also to comply with your institutional or governmental
    regulations for working with CRISPR-Cas9 technology.'
  id: totrans-251
  prefs: []
  type: TYPE_NORMAL
  zh: 1\. gRNA 设计：首先，你需要设计针对 EGFR 基因的引导 RNA（gRNAs）。有许多在线工具可以帮助你设计具有高特异性和效率的 gRNAs，如
    CRISPOR 和 Benchling 工具。2\. 克隆：将 gRNAs 克隆到一个也表达 Cas9 核酸酶的质粒中。该质粒可以通过不同的启动子表达 gRNA
    和 Cas9，或者通过一个包含 gRNA 和 Cas9 序列的单一转录本来表达。2\. 转染：将含有 gRNA 和 Cas9 的质粒转染到 A549 细胞中。可以使用如
    Lipofectamine 3000 的脂质体试剂，并按照制造商的说明操作。3\. 验证：在 CRISPR-Cas9 系统引起双链断裂并产生 DNA 修复错误后，这将导致插入或删除（indels）破坏
    EGFR 基因，你需要验证敲除效果。可以使用基因组 DNA PCR 结合随后的 Sanger 测序或像 T7 内切酶 I 或 Surveyor 核酸酶这样的错配检测实验来确认靶位点的
    indels。4\. 功能检测：这一步涉及在蛋白水平上验证敲除效果。可以使用 Western 印迹或针对 EGFR 的免疫染色来确认蛋白水平的降低或缺失。此外，你可能还希望确定敲除对细胞功能的影响，包括对
    EGFR 下游信号传导和细胞过程如增殖和迁移的影响。5\. 验证：使用多个克隆验证结果，并重复实验以确保观察结果的一致性和可重复性。注意：在实验中始终包括适当的对照，如未转染细胞或转染了非靶向
    gRNA 的细胞，是非常重要的。此外，请遵守你的机构或政府对 CRISPR-Cas9 技术的相关规定。
- en: 'Note: The answer is incomplete in multiple ways. 1\. It does not tell the users
    to first select the CRISPR system. 2\. It does not provide users with necessary
    sgRNA sequences. 3\. It does not provide the protocol for the users to do the
    cloning and transfection. In addition, it provides repetitive information on verification
    but not the details.'
  id: totrans-252
  prefs: []
  type: TYPE_NORMAL
  zh: 注意：答案在多个方面不完整。1\. 它没有告诉用户首先选择 CRISPR 系统。2\. 它没有提供必要的 sgRNA 序列。3\. 它没有提供用于克隆和转染的协议。此外，它提供了重复的验证信息，但没有细节。
- en: 'Example 2:'
  id: totrans-253
  prefs:
  - PREF_H4
  type: TYPE_NORMAL
  zh: 示例 2：
- en: 'Prompt: How should I transfect the CRISPR knockout system into 293FT cells?'
  id: totrans-254
  prefs: []
  type: TYPE_NORMAL
  zh: 提示：我应该如何将 CRISPR 敲除系统转染到 293FT 细胞中？
- en: 'GPT4: For transfection of 293FT cells with CRISPR knockout systems, lipofection
    is often used. Below are general steps: 1\. Cell Culture: 293FT cells should be
    cultured under appropriate conditions (usually DMEM supplemented with 102\. Plasmid
    DNA Preparation: Prepare your CRISPR plasmids that include Cas9 and your designed
    sgRNA. Make sure the plasmid DNA is pure and of high quality. 3\. Transfection
    Using Lipofectamine: For 293FT cells, Lipofectamine 2000 or Lipofectamine 3000
    is commonly used. Prepare the transfection complex by diluting the Lipofectamine
    reagent and plasmid DNA in Opti-MEM and combining them. Incubate the mixture for
    5-20 minutes at room temperature to allow complex formation. 4\. Transfection:
    Remove the growth medium from your cells, replace with fresh medium, and add the
    Lipofectamine-DNA complex to the cells. 5\. Post-transfection Culture: Incubate
    the cells at 37^∘C in a CO2 incubator. Typically, gene editing is allowed to proceed
    for 48-72 hours before analysis. 6\. Verification: After 48-72 hours, assess the
    transfection efficiency and gene editing effect. This is a general protocol and
    it’s important that you optimize the conditions (like the ratio of Lipofectamine
    to DNA, incubation time, etc.) based on the specific requirements of your experiment.
    And always remember to include appropriate controls in your experiment to validate
    your results. Note: Follow all relevant institutional guidelines for genetic manipulation
    and cell culture to ensure biohazard safety.'
  id: totrans-255
  prefs: []
  type: TYPE_NORMAL
  zh: 'GPT4: 对于使用CRISPR敲除系统转染293FT细胞，通常使用脂质转染法。以下是一般步骤：1. 细胞培养：293FT细胞应在适当条件下培养（通常使用补充有10%胎牛血清的DMEM）。2.
    构建质粒DNA：准备包含Cas9和设计的sgRNA的CRISPR质粒。确保质粒DNA纯净且质量高。3. 使用Lipofectamine转染：对于293FT细胞，通常使用Lipofectamine
    2000或Lipofectamine 3000。通过将Lipofectamine试剂和质粒DNA稀释在Opti-MEM中并将它们结合来准备转染复合物。将混合物在室温下孵育5-20分钟以形成复合物。4.
    转染：从细胞中去除培养基，加入新鲜培养基，并将Lipofectamine-DNA复合物添加到细胞中。5. 转染后培养：在37°C的CO2培养箱中孵育细胞。通常，基因编辑允许进行48-72小时后进行分析。6.
    验证：在48-72小时后，评估转染效率和基因编辑效果。这是一个一般的协议，重要的是根据实验的具体要求优化条件（如Lipofectamine与DNA的比例、孵育时间等）。并且始终记得在实验中包含适当的对照以验证结果。注意：遵循所有相关的机构指南，以确保生物危害安全。'
- en: 'Note: The answer is incomplete as it did not provide the quantity of cells/plasmids/Lipofectamine
    reagents which are necessary to perform the experiment.'
  id: totrans-256
  prefs: []
  type: TYPE_NORMAL
  zh: 注意：答案不完整，因为没有提供进行实验所需的细胞/质粒/Lipofectamine试剂的数量。
- en: 'A.2.1 Example 3:'
  id: totrans-257
  prefs:
  - PREF_H4
  type: TYPE_NORMAL
  zh: A.2.1 示例3：
- en: 'Prompt: How should I evaluate the CRISPRa activation efficiency of human EGFR
    in 293FT cells?'
  id: totrans-258
  prefs: []
  type: TYPE_NORMAL
  zh: 'Prompt: 如何评估在293FT细胞中人EGFR的CRISPRa激活效率？'
- en: 'GPT4: To evaluate the activation efficiency of CRISPRa (CRISPR activation)
    of the human EGFR gene in 293FT cells, you can use several methods: 1\. Quantitative
    RT-PCR (qRT-PCR): This technology can be used to quantify the mRNA level of EGFR.
    If the CRISPRa system is working efficiently, you should observe an increase in
    EGFR mRNA levels compared to your control group. 2\. Western Blot: You can also
    confirm the protein expression level of EGFR using Western blot after the gene
    has been activated. An efficient CRISPRa should result in an increase in EGFR
    protein levels. 3\. Flow Cytometry or Immunofluorescence: These methods can be
    used to quantify and visualize the level of EGFR protein expression at single-cell
    resolution. 4\. Cellular Assays: Depending on the exact function of EGFR in your
    cells, you could use a variety of cellular assays (proliferation assays, wound
    healing assays, etc.) to observe the functional outcomes of the EGFR gene activation.
    5\. Next-Generation Sequencing: RNA-seq can be used not only to confirm the overexpression
    of EGFR but also to explore the downstream effects of its activation on a transcriptome-wide
    scale. 6\. Off-target Analysis: Whole-genome sequencing or methods like Digenome-seq,
    GUIDE-seq, or CIRCLE-seq can be used to evaluate potential off-target gene activation
    by your CRISPRa system. It’s essential to include appropriate controls and perform
    experiments in replicates to ensure reliable results. Carry out normalization
    properly when quantifying the gene expression. Finally, it’s recommended to confirm
    the activation efficiency with at least two independent methods such as qRT-PCR
    and Western blot.'
  id: totrans-259
  prefs: []
  type: TYPE_NORMAL
  zh: 'GPT4: 要评估 CRISPRa（CRISPR 激活）在 293FT 细胞中对人类 EGFR 基因的激活效率，你可以使用几种方法：1. 定量 RT-PCR（qRT-PCR）：该技术可用于定量
    EGFR 的 mRNA 水平。如果 CRISPRa 系统有效，你应观察到与对照组相比，EGFR mRNA 水平的增加。2. Western Blot：在基因激活后，你还可以使用
    Western blot 确认 EGFR 蛋白表达水平。有效的 CRISPRa 应该会导致 EGFR 蛋白水平的增加。3. 流式细胞术或免疫荧光：这些方法可以用于定量和可视化单细胞分辨率下的
    EGFR 蛋白表达水平。4. 细胞学测定：根据 EGFR 在你的细胞中的具体功能，你可以使用多种细胞学测定（增殖测定、伤口愈合测定等）来观察 EGFR 基因激活的功能性结果。5.
    下一代测序：RNA-seq 不仅可以确认 EGFR 的过表达，还可以探索其激活对转录组范围的下游影响。6. 非靶标分析：全基因组测序或如 Digenome-seq、GUIDE-seq、CIRCLE-seq
    等方法可以用于评估 CRISPRa 系统可能的非靶标基因激活。包含适当的对照并在重复实验中进行，以确保结果的可靠性是至关重要的。定量基因表达时要正确进行归一化。最后，建议使用至少两种独立的方法，如
    qRT-PCR 和 Western blot 来确认激活效率。'
- en: 'Note: The answer does not provide detailed information on how to perform the
    experiment using each of the method mentioned.'
  id: totrans-260
  prefs: []
  type: TYPE_NORMAL
  zh: 注意：答案没有提供如何使用上述每种方法进行实验的详细信息。
- en: Appendix B Prompt Formats
  id: totrans-261
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 附录 B 提示格式
- en: B.1 The prompt format of the task decomposition.
  id: totrans-262
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: B.1 任务分解的提示格式。
- en: We use the following prompt format for task decomposition for the LLM planner
    in the automation mode. The LLM planner interprets the user’s request and decomposes
    it into a list of tasks. The LLM planner is prompted to respect the task dependencies
    stated in the Task Description Table.
  id: totrans-263
  prefs: []
  type: TYPE_NORMAL
  zh: 我们使用以下提示格式来进行任务分解，用于自动化模式下的 LLM 规划器。LLM 规划器解释用户的请求并将其分解为任务列表。LLM 规划器被提示遵循任务描述表中列出的任务依赖关系。
- en: 'Please  act  as  an  expert  in  CRISPR  technology.  Given  the  user  input,  think  step  by  step  and  generate  a  list  of  tasks  for  execution.  First  refer  to  the  task  description  table  below,  and  try  to  figure  out  if  the  user  needs  to  directly  jump  into  a  task,  or  the  user  needs  to  complete  several  tasks.  Make  sure  to  respect  the  task  depedencies  and  include  all  dependent  tasks  in  the  list.Please  format  your  response  and  make  sure  it  is  parsable  by  JSON.##  Task  Description  Table{Task  Description  Table}##  Demonstrations:If  the  user  only  needs  to  design  guideRNA  for  knockout,  then  return  [’knockout.StateStep1’,  ’knockout.StateStep3’].  Reason:  this  directly  matches  knockout.StateStep3.  But  it  needs  to  complete  knockout.StateStep1  first,  so  both  ’knockout.StateStep1’  and  ’knockout.StateStep3’  are  returned.User  Input:"{user_message}"Response  format:{{"Thoughts":  "","Tasks":  ["",  ""]  ##  a  list  of  task  names}}'
  id: totrans-264
  prefs: []
  type: TYPE_NORMAL
  zh: '请作为CRISPR技术的专家。根据用户输入，逐步思考并生成任务列表以供执行。首先参考下面的任务描述表，尝试弄清楚用户是否需要直接进入某个任务，或是否需要完成多个任务。务必尊重任务依赖关系，并在列表中包含所有相关任务。请格式化你的回复，并确保其可以被JSON解析。##
    任务描述表{任务描述表}## 演示：如果用户只需要设计用于敲除的guideRNA，则返回[’knockout.StateStep1’，’knockout.StateStep3’]。理由：这直接匹配knockout.StateStep3。但需要先完成knockout.StateStep1，因此返回’knockout.StateStep1’和’knockout.StateStep3’。用户输入："{user_message}"回复格式：{{"Thoughts":
    "", "Tasks": ["", ""] ## 任务名称列表}}'
- en: The task description table contains all the implemented tasks and their dependencies;
    see Table 1 for details.
  id: totrans-265
  prefs: []
  type: TYPE_NORMAL
  zh: 任务描述表包含所有已实施的任务及其依赖关系；详细信息请参见表1。
- en: 'For  knockouttask  name:  task  descriptions:  dependencyknockout.StateStep1:  Cas  System  selection  for  knockout  :  noneknockout.StateStep2:  Delivery  approach  selection  for  knockout  :  noneknockout.StateStep3:  guideRNA  design  for  knockout  :  needs  to  complete  knockout.StateStep1  firstknockout.StateStep4:  Experimental  Protocol  Selection  for  knockout  :  needs  to  complete  knockout.StateStep2  firstknockout.StateStep4_5_1_Sanger:  Primer  Design  for  knockout,  Mutation  sequencing  by  Sanger  :  noneknockout.StateStep4_5_1_NGS:  Primer  Design  for  knockout,  Mutation  sequencing  by  next-generation  sequencing  (NGS)  :  noneFor  base  editingtask  name:  task  descriptions:  dependencybase_editing.StateStep1:  Base  Editor  System  selection  for  base  editing  :  nonebase_editing.StateStep2:  guideRNA  design  for  base  editing  :  needs  to  complete  base_editing.StateStep1  firstbase_editing.StateStep3:  Delivery  approach  selection  for  base  editing  :  nonebase_editing.StateStep4:  Experimental  Protocol  Selection  for  base  editing  :  needs  to  complete  base_editing.StateStep3  firstbase_editing.StateStep4_5_1_Sanger:  Primer  Design  for  base  editing,  Mutation  sequencing  by  Sanger  :  nonebase_editing.StateStep4_5_1_NGS:  Primer  Design  for  base  editing,  Mutation  sequencing  by  next-generation  sequencing  (NGS)  :  noneFor  prime  editingtask  name:  task  descriptions:  dependencyprime_editing.StateStep1:  Prime  Editing  System  selection  for  prime  editing  :  noneprime_editing.StateStep2:  Delivery  approach  selection  for  prime  editing  :  noneprime_editing.StateStep3:  pegRNA  design  for  prime  editing  :  needs  to  complete  prime_editing.StateStep1  firstprime_editing.StateStep4:  Experimental  Protocol  Selection  for  prime  editing  :  needs  to  complete  prime_editing.StateStep2  firstprime_editing.StateStep4_5_1_Sanger:  Primer  Design  for  prime  editing,  Mutation  sequencing  by  Sanger  :  noneprime_editing.StateStep4_5_1_NGS:  Primer  Design  for  prime  editing,  Mutation  sequencing  by  next-generation  sequencing  (NGS)  :  noneFor  CRISPRa/CRISPRitask  name:  task  descriptions:  dependencyact_rep.StateStep1:  Activation  or  repression  system  selection  for  CRISPRa/CRISPRi  :  noneact_rep.StateStep2:  Delivery  approach  selection  for  CRISPRa/CRISPRi  :  noneact_rep.StateStep3:  guideRNA  design  for  CRISPRa/CRISPRi  :  needs  to  complete  act_rep.StateStep1  firstact_rep.StateStep4:  Experimental  Protocol  Selection  for  CRISPRa/CRISPRi  :  needs  to  complete  act_rep.StateStep2  firstact_rep.StateStep4_5_1:  Primer  Design  for  CRISPRa/CRISPRi,  qPCR  :  noneFor  Off-Target  Predictiontask  name:  task  descriptions:  dependencyoff_target.StateStep1:  Off-target  search/predictiono  using  CRISPRitz:  none'
  id: totrans-266
  prefs: []
  type: TYPE_NORMAL
  zh: 对于 knockouttask 名称：任务描述：依赖关系knockout.StateStep1：用于 knockout 的 Cas 系统选择：无knockout.StateStep2：用于
    knockout 的递送方法选择：无knockout.StateStep3：用于 knockout 的 guideRNA 设计：需要先完成 knockout.StateStep1knockout.StateStep4：用于
    knockout 的实验方案选择：需要先完成 knockout.StateStep2knockout.StateStep4_5_1_Sanger：用于 knockout
    的引物设计，Sanger 突变测序：无knockout.StateStep4_5_1_NGS：用于 knockout 的引物设计，下一代测序 (NGS) 突变测序：无对于
    base_editingtask 名称：任务描述：依赖关系base_editing.StateStep1：用于 base editing 的 Base Editor
    系统选择：无base_editing.StateStep2：用于 base editing 的 guideRNA 设计：需要先完成 base_editing.StateStep1base_editing.StateStep3：用于
    base editing 的递送方法选择：无base_editing.StateStep4：用于 base editing 的实验方案选择：需要先完成 base_editing.StateStep3base_editing.StateStep4_5_1_Sanger：用于
    base editing 的引物设计，Sanger 突变测序：无base_editing.StateStep4_5_1_NGS：用于 base editing
    的引物设计，下一代测序 (NGS) 突变测序：无对于 prime_editingtask 名称：任务描述：依赖关系prime_editing.StateStep1：用于
    prime editing 的 Prime Editing 系统选择：无prime_editing.StateStep2：用于 prime editing
    的递送方法选择：无prime_editing.StateStep3：用于 prime editing 的 pegRNA 设计：需要先完成 prime_editing.StateStep1prime_editing.StateStep4：用于
    prime editing 的实验方案选择：需要先完成 prime_editing.StateStep2prime_editing.StateStep4_5_1_Sanger：用于
    prime editing 的引物设计，Sanger 突变测序：无prime_editing.StateStep4_5_1_NGS：用于 prime editing
    的引物设计，下一代测序 (NGS) 突变测序：无对于 CRISPRa/CRISPRitask 名称：任务描述：依赖关系act_rep.StateStep1：用于
    CRISPRa/CRISPRi 的激活或抑制系统选择：无act_rep.StateStep2：用于 CRISPRa/CRISPRi 的递送方法选择：无act_rep.StateStep3：用于
    CRISPRa/CRISPRi 的 guideRNA 设计：需要先完成 act_rep.StateStep1act_rep.StateStep4：用于 CRISPRa/CRISPRi
    的实验方案选择：需要先完成 act_rep.StateStep2act_rep.StateStep4_5_1：用于 CRISPRa/CRISPRi 的引物设计，qPCR：无对于
    Off-Target Predictiontask 名称：任务描述：依赖关系off_target.StateStep1：Off-target 搜索/预测o
    使用 CRISPRitz：无
- en: B.2 The format of the prompt for LLM-agent.
  id: totrans-267
  prefs:
  - PREF_H3
  type: TYPE_NORMAL
  zh: B.2 LLM-agent 的提示格式。
- en: We synthesize the relevant information into `{system_message}`, including the
    instruction of the current state, the interaction history between the agent and
    the system, and potentially the results from external tools and libraries. Next,
    we supply the meta request of the user in `{meta_prompt}`. Then we prompt the
    LLM-agent to understand the current state and make decisions on behalf of the
    user.
  id: totrans-268
  prefs: []
  type: TYPE_NORMAL
  zh: 我们将相关信息合成到 `{system_message}` 中，包括当前状态的指令、代理与系统之间的互动历史，以及外部工具和库的结果。接着，我们将用户的元请求提供到
    `{meta_prompt}` 中。然后，我们提示 LLM-代理理解当前状态，并代表用户做出决策。
- en: 'Please  act  as  you  are  using  the  CRISPR  design  tool.  Given  the  user  meta  request,  the  current  inquiry  provided  by  the  tool,  think  step  by  step  and  generate  an  answer  to  the  questions.  Please  format  your  response  and  make  sure  it  is  parsable  by  JSON.Rules:1.  Answer  the  inquiry  directly  on  behalf  of  the  user.  Don’t  raise  any  additional  question  to  the  user.2.  If  the  inquiry  is  a  multiple-choice  question,  then  directly  output  one  choice.3.  If  the  inquiry  asks  you  to  supply  any  gene  sequence,  then  answer  the  question  with  "I  don’t  know"  and  let  the  user  take  manual  control.User  Meta  Request:"{meta_prompt}"Current  Inquiry:"{system_message}"Response  format:{{"Thoughts":  "","Answer":  ""}}'
  id: totrans-269
  prefs: []
  type: TYPE_NORMAL
  zh: '请假设你在使用 CRISPR 设计工具。根据用户的元请求、工具提供的当前查询，逐步思考并生成对问题的回答。请格式化你的回应，并确保其可以被 JSON
    解析。规则：1. 直接代表用户回答查询。不要向用户提出任何额外问题。2. 如果查询是多项选择题，则直接输出一个选项。3. 如果查询要求你提供任何基因序列，则回答“我不知道”，让用户手动控制。用户元请求：“{meta_prompt}”
    当前查询：“{system_message}” 回应格式：{{“Thoughts”: “”, “Answer”: “”}}'
- en: Appendix C The Rubrics for Human Evaluations
  id: totrans-270
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 附录 C 人工评估标准
- en: 'We evaluate the performance of CRISPR-GPT agent against ChatGPT v3.5 and ChatGPT
    v4 in four different aspects: Accuracy, Reasoning, Completeness and Conciseness.
    The detailed rubrics for expert evaluation are listed below.'
  id: totrans-271
  prefs: []
  type: TYPE_NORMAL
  zh: 我们评估 CRISPR-GPT 代理在四个不同方面的表现：准确性、推理、完整性和简洁性。专家评估的详细标准列在下面。
- en: Accuracy
  id: totrans-272
  prefs: []
  type: TYPE_NORMAL
  zh: 准确性
- en: •
  id: totrans-273
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '1 (Poor): The answer contains multiple factual errors or shows a misunderstanding
    of CRISPR technology.'
  id: totrans-274
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 1（差）：答案包含多个事实错误或对 CRISPR 技术的理解有误。
- en: •
  id: totrans-275
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '2 (Fair): The answer has some correct elements but also includes significant
    inaccuracies that could lead to flawed experimental design if followed.'
  id: totrans-276
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 2（一般）：答案有一些正确的元素，但也包含显著的不准确性，如果跟随可能导致实验设计出现缺陷。
- en: •
  id: totrans-277
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '3 (Average): The answer is mostly accurate but may contain minor errors or
    oversights.'
  id: totrans-278
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 3（一般）：答案大致准确，但可能包含小错误或遗漏。
- en: •
  id: totrans-279
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '4 (Good): The answer is accurate, with only negligible errors that do not impact
    the overall validity of the information provided.'
  id: totrans-280
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 4（好）：答案准确，只有微不足道的错误，不影响提供信息的整体有效性。
- en: •
  id: totrans-281
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '5 (Excellent): The answer is completely accurate, reflecting the current state
    of CRISPR research and methodologies.'
  id: totrans-282
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 5（优秀）：答案完全准确，反映了当前 CRISPR 研究和方法的状态。
- en: Reasoning
  id: totrans-283
  prefs: []
  type: TYPE_NORMAL
  zh: 推理
- en: •
  id: totrans-284
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '1 (Poor): The reasoning behind the answer is flawed or nonexistent; the logic
    is unclear or incorrect.'
  id: totrans-285
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 1（差）：答案的推理存在缺陷或不存在；逻辑不清晰或不正确。
- en: •
  id: totrans-286
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '2 (Fair): The answer provides a rationale, but it is weak and may not support
    the conclusion or design effectively.'
  id: totrans-287
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 2（一般）：答案提供了理由，但理由较弱，可能无法有效支持结论或设计。
- en: •
  id: totrans-288
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '3 (Average): The answer’s reasoning is solid for the most part, with some areas
    that could be better supported or explained.'
  id: totrans-289
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 3（一般）：答案的推理大部分是可靠的，但有些地方可以得到更好的支持或解释。
- en: •
  id: totrans-290
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '4 (Good): The answer provides strong reasoning with clear and logical support
    for all claims and suggestions made.'
  id: totrans-291
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 4（好）：答案提供了强有力的推理，清晰且逻辑性强，支持所有声明和建议。
- en: •
  id: totrans-292
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '5 (Excellent): The answer’s reasoning is exceptional, providing insightful,
    well-supported explanations that enhance understanding of CRISPR designs.'
  id: totrans-293
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 5（优秀）：答案的推理出色，提供了有洞察力、支持良好的解释，增强了对 CRISPR 设计的理解。
- en: Completeness
  id: totrans-294
  prefs: []
  type: TYPE_NORMAL
  zh: 完整性
- en: •
  id: totrans-295
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '1 (Poor): The answer is incomplete and lacks critical information required
    to form a complete understanding or action plan.'
  id: totrans-296
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: 1（差）：答案不完整，缺乏形成完整理解或行动计划所需的关键信息。
- en: •
  id: totrans-297
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '2 (Fair): The answer covers some necessary points but omits several important
    aspects that would be needed for a thorough CRISPR design.'
  id: totrans-298
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '2 (尚可): 答案涵盖了一些必要的要点，但遗漏了几个对于全面CRISPR设计所需的重要方面。'
- en: •
  id: totrans-299
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '3 (Average): The answer is fairly comprehensive but could be improved with
    additional details or coverage of more nuanced aspects of the design.'
  id: totrans-300
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '3 (一般): 答案相当全面，但可以通过增加细节或覆盖设计中更细微的方面来改进。'
- en: •
  id: totrans-301
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '4 (Good): The answer is thorough, covering nearly all aspects required for
    a complete understanding and successful experimental setup.'
  id: totrans-302
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '4 (优秀): 答案全面，涵盖了完成理解和成功实验设置所需的几乎所有方面。'
- en: •
  id: totrans-303
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '5 (Excellent): The answer is entirely comprehensive, leaving no question unanswered
    and providing a full suite of information needed for CRISPR experimental design.'
  id: totrans-304
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '5 (优秀): 答案完全全面，没有遗漏任何问题，提供了进行CRISPR实验设计所需的全部信息。'
- en: Conciseness
  id: totrans-305
  prefs: []
  type: TYPE_NORMAL
  zh: 简洁性
- en: •
  id: totrans-306
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '1 (Poor): The answer is overly verbose and contains much irrelevant information,
    making it difficult to extract useful insights.'
  id: totrans-307
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '1 (差): 答案过于冗长，包含了许多无关的信息，难以提取有用的见解。'
- en: •
  id: totrans-308
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '2 (Fair): The answer is longer than necessary with some extraneous content
    but still delivers a fair amount of relevant information.'
  id: totrans-309
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '2 (尚可): 答案比必要的长度更长，包含了一些多余的内容，但仍然提供了相当多的相关信息。'
- en: •
  id: totrans-310
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '3 (Average): The answer conveys the necessary information with some unnecessary
    detail but remains clear and understandable.'
  id: totrans-311
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '3 (一般): 答案传达了必要的信息，包含了一些不必要的细节，但仍然清晰易懂。'
- en: •
  id: totrans-312
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '4 (Good): The answer is concise, with well-organized content that is directly
    relevant to the question asked, without any unnecessary information.'
  id: totrans-313
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '4 (优秀): 答案简洁，内容组织良好，直接相关于提出的问题，没有任何多余的信息。'
- en: •
  id: totrans-314
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
  zh: •
- en: '5 (Excellent): The answer is exceptionally concise, communicating the required
    information efficiently and effectively without any superfluity.'
  id: totrans-315
  prefs:
  - PREF_IND
  type: TYPE_NORMAL
  zh: '5 (优秀): 答案异常简洁，高效且有效地传达了所需的信息，没有任何多余的内容。'
- en: '![[Uncaptioned image]](img/612eadf0845f15d10a5eb34cccbd107a.png)'
  id: totrans-316
  prefs: []
  type: TYPE_IMG
  zh: '![[无标题图片]](img/612eadf0845f15d10a5eb34cccbd107a.png)'
